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The aim of the first manuscript was to examine CHD risk in women with MS by
assessing the frequency of physical inactivity and the frequency of anthropometric,
dietary, and metabolic CHD risk factors. Although participation in physical activity is
often avoided by many women with MS, some women remain physically active despite
their disability. The aim of the second manuscript was to determine whether active
women with MS were at lower C}ID risk than inactive women with MS by assessing
the differences in abdominal fat accumulation and levels of triglycerides (TG), high-
density lipoprotein-cholesterol (HDL-C), and glucose.
The study sample consisted of 123 women with MS, aged 23 to 72years
(49.9±10 years). Venous blood was collected for measurement of lipids, lipoprotein-
cholesterol, and glucose. Skinfold thicknesses and girth circumferenceswere obtained
for estimation of total and abdominal body fat. Leisure-time physical activity (LTPA)
during the previous week was assessed with a modified version of the Yale Physical
Activity Survey. LTPA during the last 12 months was assessed with the physical
activity questionnaire used in the Postmenopausal Estrogens/Progestins Intervention
Trial. Eating habits were assessed by the Block Food Frequency Questionnaire.
In thetotalsample, 27.3% bad low HDL-C, 19.8% had high TG, 8.3% had high
glucose, 68.3% reported regular participation in LTPA, 52%were abdominally obese,
and 69% exceeded recommendations for dietary fat intake. LTPAwas significantly
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INTRODUCTION: BACKGROUND AND SIGNIFICANCE
Multiple Sclerosis (MS) is an autoimmune disease by which the body's immune
system mistakenly attacks the myelin sheaths surrounding nerve fibers in the central
nervous system (87,103). Damage to the myelin sheaths disrupts smooth muscle
conduction of electrical impulses in the central nervous system causing a number of
sensory and motor impairments (87,89,103). There are currently between 250,000 and
400,000 physician-diagnosed cases of MS in the United States (3,103), and 8,000 new
cases are diagnosed each year (87). With the continual development of new
medications for the treatment of MS, persons with MS are living longer, which in turn,
increases their risk for developing age-related secondary chronic conditions including
coronary heart disease (CHD) (89,105,113). The greatest proportion of medical costs in
the United States, estimated to be between 50 billion and 100 billion dollars annually, is
directed toward the treatment of CHD (36). Therefore, in addition to the health care
burden placed on the treatment of MS, an additional health care burden exists from age-
related secondary medical problems that may arise in persons with MS.
MS affects twice as many women than men (87,113) and CHD is responsible for
the majority of deaths in women in the United States (36). In this regard, the United
States Surgeon General emphasizes the need for research focusing on preventive
measures for reducing CHD rislg specifically in women and those with disabilities
(123). The prevalence of CHD in women can be largely reduced by effective
population-based strategies aimed at lifestyle and behavior modification, including
greater participation in physical activity and reductions in dietary intake of total and
saturated fat. Physical inactivity and high dietary intake of total and saturated fat are
knownriskfactors for CHD (36,109). Physical inactivity is linked with greater
amounts of total and abdominal fat, higher circulating levels of triglycerides (TG),
lower circulating levels of high-density lipoprotein-cholesterol (HDL-C), and reduced
insulin sensitivity, which is represented by high circulating levels of insulin and glucose2
(21,31,36,123). In fact, physically inactive individuals have a twofold increased risk for
CHI) mortality relative to their physically active counterparts (82). High dietary intake
of total fat, specifically saturated fat, is linked with higher levels of total cholesterol and
low-density lipoprotein-cholesterol (LDL-C) (36), and is weakly linked with the onset
and/or progression of MS (117). Among women, high TG levels and low HDL-C levels
are stronger predictors for CHD than high levels of total cholesterol and LDL-C (72).
In this regard, data from the Lipids Research Clinics' Follow-up Study indicate an
almost threefold increase in cardiovascular disease death among women with low
circulating levels of HDL-C (50 mg/dL) relative to women with high circulating
levels of HDL-C (>50 mgldL). Furthermore, in the presence of low HDL-C levels, high
TG levels (200mgIdL) are associated with an eightfold increase in cardiovascular
disease death in women (72). Physical activity improves circulating levels of TG and
HDL-C by stimulating lipoprotein lipase, a key enzyme responsible for the degradation
of TG and formation of HDL-C, and inhibiting hepatic lipase and cholesterol ester
transfer protein, key enzymes responsible for the degradation of BDL-C (2 1,59,82,126).
Insulin resistance, manifested by a loss of sensitivity of the body's tissues to
insulin, causes circulating levels of glucose to rise and is responsible for the onset of
noninsulin dependent diabetes mellitus (NIDDM) (96,98). Insulin resistance is believed
to be largely responsible for CuD-related metabolic disorders including high levels of
TG and low levels of HDL-C (21,24,57). In fact, theriskfor cardiovascular disease is
three times higher in diabetic women relative to their nondiabetic counterparts (55).
Physical activity reduces CHDriskby improving the sensitivity of receptors on target
tissues toinsulin,which in turn stimulates the target tissues to remove glucose from the
circulation (21,124).
Increasing amounts of total body and abdominal fat are associated with, and
may precede, increases in circulating levels of TG (13,21,24,25,88,91,92), decreases in
circulating levels of HDL-C (13,17,21,24,25,88,91,92), and insulin resistance
(2 1,24,57,88). Abdominal fat accumulation is believed to be an even more important
determinant of diseaseriskthan total body adiposity (2 1,24,57). More specifically,
increases in lipolytic activity of abdominal fat cells contribute to high levels of plasma
free fatty acids, which may be the initial metabolic disorder responsible for insulin3
resistance and unfavorable levels of TG and HDL-C (2 1,24). Recent evidence suggests
that the waist circumference may be the most accurate anthropometric measure of
abdominal and visceral (intra-abdominal) obesity in women (91). Waist circumferences
greater than 80 cm are associated with increased health risks, and waist circumferences
greater than 96.5 cm are associated with a threefold increased risk for a CHI)-related
event (101). Physical activity is believed to attenuate the age-related increases in total
and abdominal obesity and their associated metabolic and hormonal disturbances (21).
Because the symptoms of MS can profoundly interfere with and limit
participation in life activities and health promotion practices (113,114,115), in
particular, physical activity, by women with MS, they may be at additionalriskfor
CR1) as they age. Limited research suggests that women with MS are less active than
age-matched women without MS (76,87). In fact, just the diagnosis of MS,
independent from the clinical status and severity of MS, is believed to be responsible
for the low physical activity levels in women with MS (76). Thus, the aim of the first
manuscrlJt was to examine CHD risk in a sample of women with MS by assessing the
frequency ofphyical inactivity and the frequency of anthropometric, dietary, and
metabolic CHD risk factors. The aim of the first manuscript was intended to determine
whether women with MS were at greaterriskfor CHD than the general population of
women without MS by comparing physical activity practices, body composition, dietary
habits, and metabolic measurements in the present sample of women with MS to the
general population of women screened from large population surveys including the
Behavioral Risk Factor Surveillance System (BRFSS) (93,123), the National Health
Interview Survey (NHIS) (123), the third National Health and Nutritional Examination
Survey (NHANES ifi) (38), and the Lipids Research Clinics' Follow-up Study (72).
The National Cholesterol Education Program (36), the American Heart
Association (39), and the United States Surgeon General (123) strongly recommend
physical activity as a principal component of primary CHDrisk factor management
aimed at lowering abdominal fat accumulation, lowering levels of TG,raisinglevels of
HDL-C, and improving insulin sensitivity. Although participation in physical activity is
avoided by many women with MS (76,114), some women remain physically active
despite their disability. At present, it is unknown whether women with MS are able to4
participate in enough physical activity to achieve health-related benefits and to reduce
their risk for CHD. Thus, the aim of the second manuscript was to assess the d[ferences
in abdominal fat accumulation and levels of TG, glucose, and HDL-C between women
with MS reporting greater participation in higher intensity physical activity and
inactive women with MS. The aim of the second manuscript was intended to determine
what intensity of physical activity might be necessary to reduce CHD riskin women
with MS.
It is undetermined whether physical activity-related improvements in the
metabolic CHDriskfactors are independent from physical activityrelated reductions in
total body and abdominal fat. Evidence from several studies suggests that favorable
levels of the metabolic CHt)riskfactors observed in physically active individuals are
mediated through lower levels of totai body and abdominal fat also observed in
physically active individuals (3 1,48,128,131). For example, Duncan et al. (29)
identified women with the greatest reduction in body fat to have the greatest rise in
HDL-C levels when combining women fromallintensity-intervention groups following
six months of exercise training.
By contrast, some evidence has demonstrated that favorable improvements in
the metabolic CHDriskfactors with physical activity can occur in the absence of fat
loss and are primarily mediated by a physical activityrelated increase in lipoprotein
lipase activity (4,19,50,56,59,104,112,120,126). In this regard, reductions in TG (19)
and glucose (50) levels and elevations in HDL-C levels (4,19,56,104) are observed
immediately following, or in the first few days that follow an acute exercise bout,
independent from a change in body composition. If exercise is not repeated, a
considerable amount of the favorable changes in TG, glucose, and HDL-C are lost
within 48 to 72 hours following the last exercise bout (19,50,56), which supports the
hypothesis that CHD riskreducing changes in the metabolic CHDriskfactors are
achieved by repeated bouts of acute exercise, whereas reductions in total body and
abdominal fat may be more related to chronic exercise training. In turn, chronic
exerciserelated reductions in body fat may have long-term additive effects on
improving the metabolic CHD risk factors achieved by repeated bouts of acute exercise.
Therefore, the second manuscript addressed whether the association between physicalactivity and the metabolic CHD risk factors was independent from levels of total body
and abdominal fat in the sample of women with MS, and whether total body fat or
abdominal fat acted as a stronger biological modulator in the causal pathway between
physical activity and the metabolic CHD risk factors.
Current physical activity recommendations endorsed by the United States
Surgeon General (123) and the Centers for Disease Control and Prevention (82)
emphasize at least 30 minutes of moderate-intensity physical activity on most days of
the week. The current physical activity recommendations are based on research which
suggests that frequent bouts of low- to moderate-intensity physical activity can lower
CHD risk similar to a single, longer bout of high-intensity physical activity
(2,29,30,54,73,123). For instance, comparable improvements in body composition
(2,30,45,54) and some metabolic CH[) risk factors (2,30) are observed between those
incorporating intermittent bouts of moderate-intensity physical activity into their daily
schedules and those participating in a single, more structured bout of physical activity at
least three times each week. When controlling for energy expenditure, comparable rises
in levels of HDL-C are observed between low- and high-intensity female walkers (29),
and comparable reductions in nomnsulin dependent diabetes mellitus risk are observed
between vigorously and moderately active women (51). Less abdominal fat
accumulation and lower levels of glucose are observed in older adults (85) and
viscerally obese older adults (84) reporting participation in low-intensity physical
activity related to daily living relative to older adults and viscerally obese older adults
reporting little or no participation in light-intensity physical activity related to daily
living. King et al. (60) report that increases in RDL-C greater than 5 mg/dL were
achieved by more than 50% of low- to moderate-intensity older adult exercisers,
whereas only 30 to 35% of high-intensity older adult exercisers achieved increases in
HDL-C levels greater than 5 mg/dL following two years of exercise intervention. The
greatest magnitude of reduction in CR1) mortality is observed in previously inactive
individuals who become lightly to moderately active (47). Therefore, the current
physical activity recommendations are intended for those who are the most inactive
because they have the most to gain from a public health standpoint (47).By encouraging frequency and diversity of physical activity, and reducing the
emphasis on the intensity of physical activity, the current physical activity guidelines
may be attainable for many women with MS. Although limited evidence suggests that
persons with MS are capable of participating in (86,87,89,108) and achieving health-
related benefits (86,87,108) associated with moderate-intensity physical activity, several
perceived barriers, including fatigue, mobility, transportation, and fear limit the extent
by which many persons with MS can effectively incorporate physical activity into their
daily lives (113,114,115). Therefore, it is essential that strategies be developed
specifically for persons with MS to overcome potential barners prohibiting participation
in physical activity practices. Furthermore, the lack of sufficient data regarding
appropriate exercise prescription guidelines necessary to reduce CBD risk and other
secondary chronic conditions in women with MS is a major obstacle to convincing
health care professionals to include exercise prescription into their existing treatment of
patients with MS. Thus, an important objective of the second manuscript was to
provide valuable information which would be helpful in establishing minimal physical
activity recommendations necessary to reduce CHD risk in women with MS'.7
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ABSTRACT
Background:The United States Surgeon General emphasizes the need for research
addressing coronary heart disease (CHD) risk in women and those with disabilities.
Health behavior habits, including physical activity and dietary habits, can influence the
risk for CHD by their association with total body and abdominal fat accumulation,
insulin sensitivity, and levels of lipids and lipoproteins. Because health promotion
practices frequently decline with increasing disability, women with multiple sclerosis
(MS) may be at additional risk for CHD as they age. Thus, the primary aim of the study
was to assess the frequency of physical inactivity and the frequency of anthropometric,
dietary, and metabolic CHD risk factors in a sample of women with MS.
Methods:The study sample consisted of 123 women with MS, aged 23 to 72 years.
Venous blood was collected for measurement of lipids, lipoprotein-cholesterol, and
glucose. Skinfold thicknesses and waist circumferences were obtained for estimation of
total body and abdominal fat Leisure-time physical activity (LTPA) during the
previous week was assessed by a modified version of the Yale Physical Activity
Survey. Eating habits were assessed by the Block Food Frequency Questionnaire. A
brief medical history questionnaire was administered to obtain information regarding
medication use, cigarette and alcohol use, and mobility levels.
Results:In the total sample, 44.6% had high total cholesterol, 22.3% had high low-
density lipoprotein-cholesterol (LDL-C), 21.5% bad high triglycerides (TG), 8.3% had
high glucose, and 27.3% had low high-density lipoprotein-cholesterol (HDL-C).
Almost 50% of the participants were overweight, 25% of participants were obese, and
52% of participants were abdominally obese. Approximately 69% of the participants
exceeded recommendations for dietary intakes of total fat, and 36% exceeded
recommendations for saturated fat. The majority of women reported regular
participation in some intensity of LTPA (68.3%). Pre- and postmenopausal women
using hormones had more favorable levels of some metabolic CHDriskfactors relative
to pre- and postmenopausal women not using hormones.
Conclusions:The majority of subjects reported participationinlight-to moderate-
intensity LTPA. Still, CHDriskin this sample of women with MS was comparable tothe CHD risk in the general population of women with respect to anthropometric,
dietary, and metabolic CHD risk factors. Because CHI) is the leadingcause of death in
women in the United States, these results emphasize the need for effective, attainable,
and attractive strategies for reducing CIII) risk in women with and without MS.10
INTRODUCTION
The majority of women with MS will live at least 90% of a full life span (103),
which increases their risk for developing age-related diseases including CHD
(89,105,113). In fact, CHD is responsible for the majority of deaths in women in the
United States (36). The prevalence of CHD in women can be largely reduced by
effective population-based strategies aimed at lifestyle and behavior modification,
including greater participation in physical activity and reductions in dietary intake of
total and saturated fat. The symptoms of MS, however, can limit the extent by which
many women with MS can effectively and consistently incorporate health promotion
practicesintotheir daily lives (113,114,115). Therefore, women with MS may be at
additionalriskfor developing CHD as they age.
Physical inactivity and high dietary intake of total and saturated fat are known
riskfactors for CHE) (36,109). Physical inactivity is linked with greater amounts of
total body and abdominal fat, higher circulating levels of TG, lower circulating levels of
HDL-C, and reduced insulin sensitivity, which is represented by high circulating levels
of insulin and glucose (21,31,36,123). In fact, physically inactive individuals have a
twofold increased risk for CHD mortality relative to their physically active counterparts
(82).Highdietary intake of total fat and saturated fat are linked with higher levels of
total cholesterol and LDL-C (36), and greater amounts of body fat (43). Among
women, high TG levels and low HDL-C levels are stronger predictors for CHD than
high levels of total cholesterol and LDL-C (72). In this regard, data from the Lipids
Research Clinics' Follow-up Study indicate an almost threefold increase in
cardiovascular disease death among women with low circulating levels of HDL-C (50
mg/dL) relative to women withhighcirculating levels of HDL-C (>50 mg/dL) (72). In
the presence of low HDL-C levels, high TG levels (? 200 mg/dL) are associated with an
eightfold increase in cardiovascular disease death in women (72).
Insulin resistance, manifested by a loss of sensitivity of the body's tissues to
insulin, causes circulating levels of glucose to rise (96,98) and is associated with high
TG and low HDL-C levels (2 1,24,57). Furthermore, increasing amounts of abdominal
fat are associated with, and are believed to precede, increases in levels of TG11
(13,21,24,25,88,91,92) and glucose (21,24,57,88), and decreases in levels of HDL-C
(13,17,21,24,25,88,91,92).
Current physical activity recommendations, endorsed by the United States
Surgeon General (123), the Centers for Disease Control and Prevention (82), and the
American Heart Association (109), emphasize at least 30 minutes of moderate-intensity
physical activity on most days of the week. The National Cholesterol Education
Program (36) and the American Heart Association (109) recommend that dietary intake
of total fat be 30% or less oftotalcaloric intake, and dietary intake of saturated fat be
10% or less of total caloric intake. Recommendations for anthropometric indices of
body composition for women include body mass index (BMI) to be less than 25kg/rn2
(43,135), waist circumference to be less than 80 cm (135), and total adiposity to be less
than 35% (70). Recommendations for fasting levels of lipids, lipoproteins, and glucose
for women are as follows (36,72): total cholesterol <200 mg/dL; LDL-C < 130 mg/dL;
TG < 200 mg/dL; HDL-C> 50 mg/dL; and glucose <110 mg/dL.
The primaly aim of the study was to examine CHD risk in women with MS' by
assessing the frequency of inactivity and the frequency of anthropometric, dietary, and
metabolic CHD risk factors in a sampleofwomen with M. The primary aim was
intended to determine whether women with MS were at greater risk for CHD than the
general population of women without MS by comparing physical activity practices,
bodycomposition, dietary habits, and metabolic measurements in the present sample of
women with MS to the general population of women screened from large population
surveys including the Behavioral Risk Factor Surveillance System (BRFSS) (93,123),
the National Health Interview Survey (NHIS) (123), the third National Health and
Nutritional Examination Survey (NHANES ifi) (38), and the Lipids Research Clinics'
Follow-upStudy(72).
In addition, because hormone use is known to influence the metabolic CHDrisk
factors (15,52,136), the frequency of high levels of total cholesterol, LDL-C, TG, and
glucose,andlow levels of HDL-C were examined in poshnenopausal women using
hormone replacement therapy (HRT) and postinenopausal women not using HRT, and12
inpremenopausal women using oral contraceptives and premenopausal women not
using oral contraceptives, in order to determine whether hormone users with MS' were
at lower CHD risk than nonhormone users with MS.13
METHODS
The present study was a descriptive study examining the health behaviors, body
composition, and lipid, lipoprotein-cholesterol, and glucose levels in women with MS.
Women volunteers (n=123) were recruited from Oregon MS chapters, physician
referrals, and newspaper announcements. Women with diagnosed cardiovascular
disease, insulin-treated diabetes, gout, or recently diagnosed thyroid disorder, and
women who currently used oral prednisone, smoked more than ten cigarettes per day, or
consumed more than four alcoholic beverages per day were excluded. All subjects had
physician-diagnosed MS.
Official approval for the research project was granted by Oregon State
University, Corvallis; Rogue Valley Medical Center, Medford; and Oregon Health
Sciences University, Portland. The Institutional Review Board proposal is included in
appendix A. Data was collected from the MS clinic at Oregon Health Sciences
University, the Health and Human Performance Lab at Oregon State University, the
Asante Health Promotion offices at Rogue Valley Medical Center, the Springfield
Willamalane Senior Activity Center, the Three Rivers Hospital in Grants Pass, and the
Salem Hospital Rehabilitation Center. An informed consent was completed by each
participant prior to data collection. The informed consent form is included in appendix
B.
Assessment of Lipids. Lipoprotein-Cholesterol, and Glucose
Venous blood (< 10 ml) was collected by venipuncture following a 12-hour fast
by trained lab technicians using sterile procedures. Firm pressure and a bandage was
applied to the venipuncture site immediately following blood collection. Serum and red
blood cells were separated by centrifligation at 1900 x g for 15 minutes. The serum was
transferred to plastic, labeled vials and frozen at _700 C for later analysis of
lipid/lipoprotein-cholesterol (total cholesterol, TG, HDL-C, and LDL-C) and glucose
concentrations by Rogue Valley Medical Center.14
Quality control of the Rogue Valley Medical Center laboratory is monitored by
the Lipid Standardization Program of the Centers for Disease Control and Prevention.
Measurements of lipid/lipoprotein-cholesterol and glucose were within specific limits
established by the Lipid Standardization Program of the Centers for Disease Control
and Prevention (i.e., 2.6 SD, 1.23% CV for total cholesterol; 2.3 SD, 1.41% CV for TG;
1.2 SD, 1.89% CV for HDL-C; and 1.2 SD, 3.26% CV for glucose).
Total cholesterol concentrations were determined by enzymatic procedures in
serum with cholesterol esterase, cholesterol oxidase, and peroxidase, which produce
colored products that are analyzed with spectrophotometers (125). TG concentrations
were determined by enzymatic procedures in serum with glycerol kinase,
glyceroiphosphate oxidase, and peroxidase. Again, colored products produced are
spectrophometrically analyzed (125). HDL-C levels were detennined using the direct
EZ-HDL Sigma assay, which uses anti human 9-lipoprotein antibody to bind with LDL,
VLDL, and chylomicrons. HDL-C levels can then be directlyanalyzedby enzymatic
procedures previously described for total cholesterol. High correlations are reported for
HDL-C levels between the Sigma method and standard enzymatic methods used after
precipitation of beta lipoproteins with magnesium/dextran sulfate (r0.98). After
directly measuring the concentrations of total cholesterol, TG, and HDL-C, LDL-C can
be calculated indirectly with the Friedwald equation (40):
LDL-C = Total cholesterol HDL-C - TG/5
Glucose concentrations were determined by an oxygen rate method with a Beckman
Oxygen electrode. After adding glucose oxidase to the glucose sample, electronic
circuits measure the oxygen consumption rate, which is directly proportional to the
glucose concentration in the sample.
Because blood samples wereinitiallygoing to be analyzed by Dr. Rosemary
Wander's Lipid Laboratory at Oregon State University, all samples were collected in
plasma EDTA tubes during the first week of testing. There was, however, an
unexpected early closure and relocation of Dr. Wander's Lipid Laboratory before all
blood samples could be collected. Although the laboratory at Rogue Valley Medical
Center agreed to analyze the blood samples for lipid/lipoprotein-cholesterol and glucose
concentrations, the laboratory was unable to accurately determine total cholesterol from15
samples collected in plasma EDTA tubes, estimating 24% bias. The majority of the
participants returned the following week to have their blood recollected in serwn
separator tubes so that their total cholesterol levels could be analyzed by the Rogue
Valley Medical Center laboratory. Values for total cholesterol and LDL-C are missing
from nine subjects who participated in the study during the first week of data collection
but were unable to return for a blood redraw. Because the methods used by the Rogue
Valley Medical Center laboratory could accurately determine levels of TG, HDL-C, and
glucose obtained in the plasma EDTA tubes, concentrations of TG, HDL-C, and
glucose from the nine subjects who did not return for a blood redraw were included in
the data analysis. We were unable to obtain blood samples from two subjects. Thus, all
measurements of lipid/lipoprotein-cholesterol and glucose are missing from these two
subjects. Finally, because the Fnedwald equation, which is used to calculate LDL-C
from total cholesterol, HDL-C, and TO, is invalid when TO levels exceed 400 mg/dL,
LDL-C levels are missing from two subjects who had TG levels greater than 400
mg/dL.
Anthropometry for Assessment of Total and Abdominal Fat
Body weight was measured with a standard balance-beam scale in light clothing
without shoes at the Corvallis, Portland, Medford, and Grants Pass testing sites, and
with a digital scale at the Springfield and Salem testing sites. For participants who were
unable to stand, body weight was obtained on a chair scale when feasible. Three
participants were weighed on a chair scale. Weight was notobtainedfor five
nonambulatory participants. An estimate of weight for these five participants was
obtained from their physician. Height was measuredwithoutshoes using a stadiometer.
Participants tested at locations which lacked a stadiometer or who were unable to stand
were asked to contact their physician for their height. Measurements (and estimates) of
weight and height were used to calculate BMI.
The waist circumference was used as a measure of abdominal fat accumulation.
Waist circumference was measured with a tape measure at the narrowest portion of the
torso between the top of the iliac crest and the lowest rib. Continuous measurements of16
waist circumference were conducted until measurements were within 1 cm agreement
For the participants who were unable to stand, waist circumference was measured ina
reclining position when feasible.
Total body fat was calculated from multicomponent prediction equations using
skinfold thicknesses as an estimate of subcutaneous fat (127). Skinfold thicknesses
were measured with a Lange skinfold caliper at four sites on the right side of the body
(triceps, subscapular, abdomen, and calf) according to standardized procedures (49). To
reduce standing time for the participants, however, skinfold measurements for the
triceps, subscapular, and calf were obtained in a sitting position.. Abdominal skinfold
measurements were obtained in a standing position. For the participants unable to
stand, abdominal skinfold measurements were obtained in a reclining position.
Continuous measurements of skinfold thicknesses were conducted in rotational order
until measurements for each site were within 1 mm agreement. The sum of the four
skinfold sites were used in the following multicomponent prediction equation for
women (127).
%BF = 0.428(sum skinfolds)-0.001 1(sum of skinfolds2)+0.127(age)-3.01
The multicomponent prediction equations used in the present study. were chosen
because 1.) they were developed on women between the ages of 34 and 84,2.) they
account for individual differences in the mineral and water components of fat free mass,
3.) they yield high multiple correlation coefficients between skinfold thicknesses and
body fat (ranging from 0.88 to 0.91) and small standard error estimates (ranging from
2.6 to 3.2), and 4.) they have been used previously in the literature to estimate body fat
specifically in women with MS (86).
Physical Activity Assessment
A modified version of the second section of the Yale Physical Activity Survey
was used to gain information regarding the frequency and duration of participation in
vigorous-intensity LTPA (i.e., activities comparable to fast walking4.5 mph such as
jogging, lap swimming, stairmaster), moderate-intensity LTPA (i.e., activities
comparable to brisk walking between 3.0 mph and 4.0 mph, such as water aerobics),17
and light-intensity LTPA (i.e., activities comparable to leisurely walking between 2.0
mph and 3.0 mph, such as yoga, tai chi, and stretching). A copy of the modified Yale
Physical Activity Survey in included in appendix C.
Diet Composition
Eating habits and diet composition were assessed by the Block Food Frequency
Questionnaire (BFFQ). The BFFQ provides valid and reliable information regarding
dietary intake of total fat, saturated fat, and nutritional supplements (8). The BFFQwas
analyzed by Block Dietary Data Systems. A copy of the BBFQ is included in
appendix D.
Medical History
A brief medical history questionnaire was administered to obtain information
regarding medication and hormone use, current and past cigarette use, alcohol
consumption, and mobility levels. A copy of the medical history questionnaire is
included in appendix E.
Statistics
Summary statistics were used to report the 1.) anthropometric characteristics,
health behavioral characteristics, metabolic characteristics, and medicationuse of the
participants, and 2.) frequency of anthropometric, dietary, and metabolicriskfactors
associated with increased health risks among all participants, all postmenopausal
participants, all premenopausal participants, and postmenopausal and premenopausal
participants stratified on hormone use. Mean differences in the levels of total
cholesterol, LDL-C, TG, glucose, and HDL-C between postmenopausal and
premenopausal women, postmenopausal women using HRT and postmenopausal18
women not using HRT, and premenopausal women using oral contraceptives and
premenopausal women not using oral contraceptives were analyzed using independent
t-tests with an alpha level of 0.05.FL
RESULTS
Table 1.1 summarizes the anthropometric characteristics, health behavioral
characteristics, metabolic characteristics, and medication use of the participants. Mean
levels of BMI, waist circumference, and total body fat exceeded levels recommended by
the World Health Organization (135). Mean levels of dietary intake of total fat
exceeded levels recommended by the National Cholesterol Education Program (109)
and the American Heart Association (109), but mean levels of dietary intake of
saturated fat were within recommendations. The majority of the participants were
current nonsmokers (94.3%), rarely consumed alcohol (69.9%), and used some form of
multivitamin or antioxidant supplement (79.7%). Slightly less than half of the
participants met the current daily recommendations for dietary intake of vegetables
(47.7%) and fruit (47.7%). The frequency of antidepressant use was 38.2%,
postmenopausal HRT use was 74.3%, and premenopausal oral contraceptive use was
20.4%. Less than half ofthe participants were employed (42.3%).
The study sample represented a high functioning, less disabled group of women
with MS in that approximately 85.4% were ambulatory, 12.2% regularly used a
wheelchair, and only 1.6% had to be in bed most or all of the time (table 1.1). The
majority of women reported regular participation in some intensity of LTPA (light,
moderate, or vigorous) accumulating 150 minutes during the previous week.
Approximately 10.6% of women reported regular participation in vigorous-intensity
LTPA, and 31.7% reported either irregular or no participation in LTPA during the
previous week (table 1.1).20
Table 1.1: Anthropometric Characteristics, Health Behavioral Characteristics,
Metabolic Characteristics, and Medication Use of the Participants (n123)
Age. yr 499±10.0
Anthropometiic Charactenstics çvalues are means±SD)
Body Mass Index (kg/rn )(n=120) 26.0±6.5
Waist Circumference (cm')(n=122) 82.4±13.8
Body Fat (%)(n=122) 37. 1±7.9
Dietary Behaviors
Total Fat Intake (%) (mean±SD) 33.4±7.9
Saturated Fat Intake (%)(mean±SD) 9. 2±3.2
Vitamin/Antioxidant Use (# participants/percent) 98(79.7)
Vegetable Intake (>3/day) (# participants/percent) 58(47.1)
Fruit Intake (>2/day)(participants/percent) 58(47.1)
Cigarette Use (values are number participants/percent)
Current (<10/day) 7 (5.7)
Past 42(34.1)
Never 81(65.9)
Alcohol Intake (values are number participants/percent)
>1 drink/week 37(30.1)
<1 drink/week 16(13.0)
Never 70(56.9)
Mobility (values are number participants/percent)
Ambulatory (with or without aids) 106 (86.0)
Nonambulatorv (wheelchair/scooter) 15 (12.2)
Nonambulatorv (in bed mostlall of the time) 2(1.6)
Leisure Time Physical Activity (values are mnnber participants/percent)
Inactive 19 (15.4)
Ligiit'Moderate 80 (65.0)
Vigorous 13 (10.6)
Recommended 84(68.3)
Metabolic (values are means±SD)
Triglyceride (mgfdL)(n=121) 147.9±79.6
HDL-C (mgfdL')(n=121) 60.0±13.6
Glucose (mgfdL')(n=121) 92.2±11.3
Total Cholesterol (mgldLXn=l 12) 197.8±39.6
LDL-C (mgldL)(n=1 12) 107.2±33.2
Medication Use (values are number participants/percent)
Antidepressant (%) 47(38.2)
Postmenopausal HRT (%)* 55(74.3)
Premenopausal Oral Contraceptive (%)t 10(20.4)
Employment (value is number participants/percent) 52(42.3)
HDL-C, High-density lipoprotem-cholesterol*N74 postmenopausal participants
LDL-C, Low-density lipoprotein-cholesteroltN=49 premenopausal participants
HRT, Hormone Replacement Therapy21
Table 1.2 provides data regarding the frequency of participation in specific
LTPA reported by women in the present sample and women participating in the NHIS.
The most common activities reported by women participating in the present study were
gardening (50.4%), leisurely walking (49%), and stretching (25.5%). Walking for
exercise (brisk and leisure) was the leading activity reported by women from both
samples. The frequency of walking, however, was slightly greater in the present sample
(5 5.3%) relative to women participating in the NHIS (48.3%), yet leisurely walking
(49%) was reported with greater frequency than brisk walking (21.9%) in the present
sample. Swimming/water activities, strengthening exercises, and gardening were more
frequently reported by women participating in thisstudyrelative to those participating
in the NHIS. By contrast, participation in more vigorous activities (jogging, stair
climbing, and aerobics) were reported with less frequency in the present sample relative
to women from the NHIS.
Table 1.2: Participation in Common Leisure-Time Physical Activities Reported by the
Present Sample of Women with MS and Women Screened in the NHIS, 1991
Activity Category MS SamDle NHIS
Gardening 50.4% 25.1%
Walking (leisure) 49.0%
Walking (brisk)
Walking (leisure+brisk)
21.9%
55.3% 48.3%
Stetching 25.5% 24.4%
All Water Activities 20.3% 15.0%
Weight Lifting/Strengthening Exercises 13.8% 8.8%
Bicycle/Exercycle 12.2% 14.6%
Jogging 2.4% 5.7%
Stair Climbing 2.4% 11.6%
Golf 1.6% 1.8%22
Table 1.3 summarizes the frequency of anthropometric, dietaiy, and metabolic
risk factors associated with increased CHD risk among participants. In the total sample,
27.3% had low levels of HDL-C (<50 mg/dL), 2 1.5% had high levels of TG (200
mg/dL), 8.3% had high levels of glucose (?1 10 mg/dL), 44.6% had high levels of total
cholesterol (>200 mg/dL), and 22.3% had high levels of LDL-C (130 mgldL). Almost
50% of the participants were overweight (BMI25 kg/rn2) and half of these
participants were obese (BMI30 kg/rn2) as defined by the World Health Organization
(135). Approximately 68% of the participants exceeded a total adiposity of 35%, 52%
of the participants had waist circumferences exceeding 80 cm, and 16% of the
participants had waist circumferences exceeding 96.5 cm. Dietaiy intake of total fat
was greater than 30% of total caloric intake in the majority of the participants (69.1%),
and dietary intake of saturated fat was greater than 10% of total caloric intake in almost
36% of the participants.
Table 1.3: Frequency of Participants at Increased CHI) Risk from
Anthropometric, Dietary, and Metabolic Risk Factors (N=123)
Anthropometric Factors (values are number participants/percent)
>
>
Waist Circwnference> 80 cm* 63(52.0)
>96.5 cm* 19(16.0)
Body Fat> 35%* 83(68.0)
Dietary Factors (values are number participants/percent)
Total Fat Intake> 30% 85(69.1)
Saturated Fat Intake> 10% 44(35.8)
Metabolic Factors (values are number participants/percent)
HDL-C<50 mgJdL** 33(27.3)
Triglyceride> 200 mg/dL** 26(21.5)
Glucose> 110 gJ** 10(8.3)
Total Cholesterol> 200 mg/dLfl 50(44.6)
LDL-C> 130 mgldLfj' 25(22.3)
HDL-C, High-density lipoprotein-cholesterol *N122 because of missing values
LDL-C, Low-density lipoprotein-cholesterol **N121 because of missing values
tN=120 because of missing values
ttN=1 12 because of missing values23
Figure 1.1: Percent of Premenopausal and Postmenopausal Participants
at Increased CHD Risk from Metabolic Risk Factors
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Figure 1.1 displays the data summarizing the frequency of pre- and
postmenopausal women at increased CHD risk from metabolic risk factors. Among all
postmenopausal participants (n=73), 26% had low levels of HDL-C, 28.4% had high
levels of TG, 9.6% had high levels of glucose, 53.7% had high levels of total
cholesterol, and 25.4% had high levels of LDL-C. Among all premenopausal
participants (n=48), 29.2% had low levels of HDL-C, 10.4% had high levels of TG,
6.3% had high levels of glucose, 31.1% had high levels of total cholesterol, and 20%
had high levels of LDL-C. Mean levels of total cholesterol (p=O.O3) and TG(p=O.002)
were significantly lower in premenopausal women relative to postmenopausal women.24
Figure 1.2: Frequency of Postmenopausal Participantsat Increased
CHD Risk from Metabolic Risk Factors
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Figure 1.2 displays the data summarizing the frequency ofpostmenopausal
women using and not using HRT at increased CHD risk from metabolic risk factors.
Postmenopausal women using HRT (n54) hadmore favorable metabolic CHDrisk
factor profiles than postmenopausalwomen not using HRT (n=19). Mean HDL-C
levels were significantly higher (p=0.02) andmean LDL-C levels were significantly
lower (p=O.02) in postmenopausalwomen using HRT relative to postmenopausal
women not using HRT, but no significant differences were observed inmean levels of
TG, total cholesterol, or glucose between postmenopausalwomen using HRT and
postmenopausal women not using HRT. Approximately 42% ofpostmenopausal
women not using HRT had low HDL-C levels, while only 20% of postmenopausal
women using HRT had low HDL-C levels. In contrast, high TG levelswere more
frequent among postmenopausal HRTusers (31.5%) than postmenopausal HRT25
nonusers (21%). The frequency of high total cholesterol levelswas similar between
postmenopausal HRT users and postmenopausal HRTnonusers (-53%), but the
frequency of high LDL-C levelswas greater in postmenopausal women not using HRT
(47%) relative to postmenopausalwomen using HRT (18%).
Figure 1.3: Frequency of Premenopausal Participantsat Increased CHD Risk from
Metabolic Risk Factors
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Figure 1.3 displays the data summarizing thefrequency of premenopausal
women using and not using oral contraceptives at increased CHD risk frommetabolic
factors. Premenopausal women using oral contraceptives(n=lO) had more favorable
metabolic CHD-risk factor profiles thanpremenopausal women not using oral
contraceptives (n=38). Mean H])L-C levelswere significantly higher (p=O.O1) and
mean glucose levels were significantly lower (p=O.0001) in premenopausalwomen26
using oral contraceptives relative to premenopausal women not using oral
contraceptives, but no significant differences were observed in mean levels of TG, total
cholesterol, or LDL-C between premenopausal women using oral contraceptives and
premenopausal women not using oral contraceptives. Furthermore, the frequency of
low HDL-C levels was 36.8% among premenopausal women not using oral
contraceptives, whereas none of the premenopausal women using oral contraceptives
had low levels of HDL-C. Similarly, high levels of TO and glucosewere evident
among premenopausal women not using oral contraceptives (13.2% and 7.9%,
respectively), but absent in premenopausal women using oral contraceptives.27
DISCUSSION
The majority of women with MS in the present sample adopted several health-
related behaviors including regular participation in some form of physical activity,
regular use of vitamins, and limited alcohol consumption. The majority of women did
exceed recommended intakes of dietary fat, however, and slightly less than half met
current recommendations for dietary intakes of vegetables and fruits. Mean levels of
dietary intake of total fat intake among study participants are comparable to dietary
intake of total fat reported from the general population (34%) (43).
The percentage of physically active behaviors in the present sample of women
with MS exceeds the percentage of physically active behaviors reported in the general
population of women participating in the BRFSS and contradicts previous research
which suggests that women with MS have low participation in LTPA (76,87). In this
regard, 65% of women in the present sample regularly participated in light- to
moderate-intensity LTPA, 10.6% regularly participated in vigorous-intensity LTPA,
6&3% met LTPA recommendations described in the 1996 BRFSS (i.e., regular
participation in any intensity of LTPA), and 31.7% irregularly or never participated in
LTPA. By contrast, 22% of women with MS have been reported to regularly participate
in light- to moderate-intensity LTPA (114) and the 1996 BRFSS estimates that 23.1%
of women in the United States regularly participate in light- to moderate-intensity
LTPA, 15.4 % regularly participate in vigorous-intensity LTPA, 284% meet LTPA
recommendations, and 71.5% irregularly or never participate in LTPA.
Several explanations may be responsible for the high frequency ofreported
LTPA in this sample. For instance, because 85% of women participating in the present
study were ambulatory, the higher levels of LTPA in this sample relative to the levels of
LTPA previously described in women with MS (76,87) may be accounted for by greater
mobility and less disability observed in the present sample. In addition, because the
study was promoted as a health behavior study, it is likely that the present samplewas
somewhat biased towards more health conscious women. It is important to emphasize,
however, that not all nonambulatory women were inactive. In fact, five nonambulatory
women regularly participated in light physical activity and seven ambulatory women28
were inactive during their leisure-time. Furthermore, ten women who required aids for
ambulating regularly participated in light-intensity LTPA and five women who required
aids for ambulating regularly participated in moderate-intensity LTPA.
The majority of women in this study regularly participated in light- to moderate-
intensity LTPA (65%), but few participated in vigorous-intensity LTPA (10.6%). Less
participation in light- to moderate-intensity LTPA (23.1%), but greater participation in
vigorous-intensity LTPA (15.4%), however, was reported by women screened in the
BRFSS relative to women in the present sample. The high frequency of gardening
activity amongstudyparticipants (50.4%) relative to the frequency of gardening activity
described in women from the NHIS (25.1%) may be explained by the period of data
collection. In the present study, participants were asked to describe their participation
in LTPA during the preceding week. Because data was collected in the summer, the
frequency of gardening activities was high. In the NHIS, participants were asked to
describe their participation in LTPA during the preceding two weeks. Because the
NETS screens subjects year-round, the frequency of seasonal activities, such as
gardening, are systematically underestimated in persons not screened in the spring and
summer. Therefore, it is difficult to accurately compare gardening behaviors between
those participating in this study and those participating in the NHIS.
The large proportion of women meeting the recommended levels of LTPA in
this sample can also be explained by the new duration requirements described in the
1996 BRFSS, which allows light- to moderate-intensity LTPA to be accumulated in 10
minute continuous bouts as opposed to 30 minutes of sustained, continuous activity
required in previous BRFSS. These requirements are more feasible and attainable by
women with MS who may overheat and fatigue with physical activity bouts of greater
duration.
Despite the high participation in LTPA among study participants, more than half
of participants had total body fat (69.1o/)and abdominal circumferences (52%)
exceeding values recommended for health. Based on BML, almost 50% of the women
were overweight and half of these overweight women were obese according to
standards established by the World Health Organization (135). The frequency of
overweight and obesity in this sample is slightly less, but comparable to the frequency29
of overweight and obesity reported in women participating in the NHANES III (i.e.,
55%, overweight; 27%, obese) (38), which places our participants at similar risk for
medical complications arising from excess weight as the general population of women
without MS. Nevertheless, the similarities in the occurrence of overweight and obesity
between our findings and those reported from the NHANES III should not mistakenly
lead us to believe that the prevalence of overweight and obesity in women with MS is
not of considerable concern. Rather, the findings contribute to the recent literature
exposing the alarming rate at which overweight and obesity are increasing in the
American population. Obesity and, in particular, abdominal obesity, are strongly
related to, and frequently precede the onset of hypertension, noninsulin dependent
diabetes mellitus (NIDDM), and CHD (2 1,57,88,96,98). Thus, almost half of the
women in the current study are at increased risk for hypertension, NTDDM, and CHD.
Furthermore, 16% of the participants had waist circumferences exceeding 96.5 cm,
which more than triples their risk for experiencing a CHD-related event (101). The
economic cost associated with the treatment of adiposity-related illness in overweight
and obese women with MSonlyadds to the existing health care burden associated with
the treatment and management of MS-related disorders.
The frequency of high levels of TG (?200 mg/dL) and low levels of HDL-C
(50 mg/dL) among the present sample of women with MS (i.e., 2 1.5% and 27.3%,
respectively) is comparable to the frequency of high levels of TG (19.8%) and low
levels of HDL-C (27.7%) reported in women participating in the Lipids Research
Clinics' Follow-up Study (72). Findings from the Lipids Research Clinics Follow-up
Study identify women with HDL-C levels less than 50 mg/dL at threefold greater risk
for cardiovascular disease death relative to women with HDL-C levels exceeding 50
mgfdL (72). Thus, more than 25% of women with MS participating in the currentstudy
are at markedly increased risk for cardiovascular disease. It should be noted that some
research suggests that TG levels greater than 150 mg/dL are associated with substantial
increased risk for CHD (15). In the current sample, 43.8% had TG levels greater than
150 mg/dL. Most importantly, 11.5% of participants had low HDL-C levels in
combination with high TG levels, which places them at an eightfold increased risk for
cardiovascular disease death (72).30
Premenopausal women had significantly lower levels of total cholesterol and TG
relative to postmenopausal women. Consistent with data reported from major HRT
intervention trials examining CHD risk between postmenopausal women using and not
using HRT (52,136), the present sample of postmenopausal women with MS using HRT
had significantly higher levels of HDL-C and significantly lower levels of LDL-C
relative to postmenopausal women with MS not using HRT. Moreover, the percentage
of postmenopausal women not using HRT having low HDL-C levels (42.1%) and high
glucose levels (15.8%) was doubled relative to the percentage of postmenopausal
women using HRT (20.3% and 7.4%, respectively). HRT use is frequently reported to
raise TG levels (52,136). Although there was a greater percentage of postmenopausal
women using HRT havinghighlevels of TG (31.5%) relative to postmenopausal
women not using HRT (21%), no significant differences in mean TO levels were
observed between postmenopausal women using and not using HRT in the present
study.
High levels of LDL-C are not considered to be as strong a risk factor for CHD as
low levels of HDL-C in women (72). The lower percentage ofhighLDL-C levels in
the sample of postmenopausal women using HRT, however, should be appreciated. In
this regard, the percentage of postmenopausal women not using HRT having LDL-C
levels exceeding values recommended for metabolic health (47%) was 2.5 times greater
than observed in postmenopausal women using HRT (18%).
Oral contraceptives are reported to unfavorably raise levels of TG and glucose,
and lower levels of HDL-C (15). The frequencies of high levels of TG (13.2%) and
glucose (7.9%), and low levels of HDL-C (36.8%) were evident in premenopausal
women not using oral contraceptives, however, but absent in premenopausal women
using oral contraceptives. Moreover, premenopausal women using oral contraceptives
had significantly higher levels of I{DL-C and significantly lower levels of glucose
relative to premenopausal women not using oral contraceptives.
In summary, the frequency of participation in LTPA physical activity was high
in this sample of women with MS and may be explained by the following: 1.) the
majority of activities reported werelight-to moderate-intensity LTPA and 2.) the
present sample consisted of more functional, less disabled, and perhaps, more health-31
conscious women with MS. Thus, it is reasonable to believe that more disabled and less
health-conscious women with MS may be less physically active than those participating
in this study, and may, therefore, be at greater risk for CR1) than women participating in
this study. Still, the high prevalence of physically active behaviors among our
participants provides promising hope that women with MS can remain physically active
"within the context of their disability (114)."
Despite the high participation in LTPA, women with MS in this sample were at
similar CHI) risk as the general population of women without MS with respect to body
composition and levels of TG and HDL-C. The relationship between physical activity
and CHI) risk is complicated, however, and influenced by other factors including
dietaiy intake of total fat, which may interfere with the positive effects that physical
activity has on improving CHD risk. In this regard, almost 70% of women had dietary
intakes of total fat exceeding recommended levels. High dietary intake of fat may
contribute to higher levels of adiposity and unfavorable levels of the metabolic CHD
risk factors, and must be considered with respect to the frequency of anthropometric and
metabolic CHDriskfactors observed in this sample.
Because CRD risk is the leading cause of death in women in the United States,
the similarities in CR1) risk between our findings and those reported in the general
population of women emphasize the importance of improving health behavior practices
and identifying effective and attainable preventative measures for reducing CHL) risk in
women with and without MS. The development and implementation of strategies
aimed at improving health behavior practices, in particular, physical activity, is
uniquely challenging in women with MS given the limitations and fatigue imposed by
their disability. Nevertheless, adoption of better health behaviors can reduce CHD risk,
and most importantly, improve the quality of life in women with MS, such that "good or
poor health can exist in the presence or absence of overt illness or disability (114)."32
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ACTIVE AND INACTIVE WOMEN WITH MULTIPLE SCLEROSIS
Jennifer N. Slawta, Anthony R. Wilcox, Jeffrey A. McCubbin, and Darek J. Nalle
Department of Exercise and Sport Science, Oregon State University, Corvallis, OR33
ABSTRACT
Background: TheUnited States Surgeon General emphasizes the need for research
focusing on preventative measures for reducingcoronary heart disease (CHD) risk,
specifically in women and those with disabilities. Physical activity is strongly
recommended as a principal component of CHD-risk factor management aimedat
favorably lowering abdominal fat accumulation, lowering levels of triglyceride (TG),
raising levels of high-density lipoprotein-cholesterol (HDL-C), and improving insulin
sensitivity. Although physical activity practicesare reported to be low in women with
multiple sclerosis (MS), some women with MS remain physically active despite their
disability. Thus, the primary aim of the studywas to determine whether abdominal fat
accumulation and levels of TG, HDL-C, and glucose differ between active and inactive
women with MS.
Methods:The study sample consisted of 123women with MS. aged 23 to 72 years.
Venous blood was collected for measurement of lipids, lipoprotein-cholesterol, and
glucose. Skinfold thicknesses and girth circumferenceswere obtained for estimation of
total and abdominal body fat. Leisure-time physical activity (LTPA) during the last12
months was assessed by the physical activity questionnaire used in thePostmenopausal
EstrogensiProgestins Intervention Study. Eating habitswere assessed by the Block
Food Frequency Questionnaire.
Results:LTPA was significantly associated with lower waist circumference(p=O.000I),
lower TG levels (p=O.0005), lower glucose levels (0.002), and marginally with higher
HDL-C levels (p=0.09). After adjusting for the covariates (age, hormone replacement
therapy and oral contraceptive use, current and past cigaretteuse, and alcohol intake),
women participating in low- to moderate-intensity LTPA had significantly lower waist
circumferences, TG levels, and glucose levels relative to inactivewomen.
Conclucions: Low-to moderate-intensity LTPA was significantly associated with less
abdominal fat accumulation, lower levels of TG and glucose, andto some extent higher
levels of HDL-C in the present sample ofwomen with MS. These findings suggest that
exercise levels attainable by women with MSmay improve CuDriskand contribute to
important health-related benefits.34
INTRODUCTION
Women are twice as likely to develop MS than men (87,113). With the
continual development of new medications for the treatment of MS, women with MS
are living longer, which in turn increases their risk for developing age-related secondary
chronic conditions, including CHt) (89,105,113). Moreover, because women with MS
frequently have low participation in physically active behaviors (76,114), and because
physical inactivity is designated as a major CHD risk factor (36,82,123), women with
MS may be at additional risk for CHD as they age. In fact, physically inactive
individuals have a twofold increased risk for C}{D mortality relative to their physically
active counterparts (82).
Physical inactivity raises CHD risk, in part, by its association with greater
abdominal fat accumulation, higher levels of TG, lower levels of HDL-C, and reduced
insulin sensitivity, which is represented by high circulating levels of insulin and glucose
(2 1,36,123). High circulating levels of TG (200 mg/dL) and low circulating levels of
HDL-C (50 mg/dL) are strong independent biological predictors of CHD risk in
women (20,72). Reduced insulin sensitivity causes circulating levels of glucose to rise
and is frequently associated with high circulating levels of TG and low circulating
levels of HDL-C (2 1,24,57). Furthermore, increasing amounts of abdominal fat are
believed to precede and be largely responsible for reduced insulin sensitivity and
unfavorable circulating levels of TG and HDL-C (2 1,24,88).
Participation in LTPA is avoided by many women with MS (114). Some
women with MS, however, remain physically active despite their disability. At present,
it is unknown whether women with MS are able to participate in enough physical
activity to achieve health-related benefits and to reduce their risk for CHD. Thus, the
primary aim of the study was to assess the dtferences in abdominal fat accumulation
and levels of TG, HDL-C, and glucose between women with MS participating in higher
intensity LTPA and inactive women with M. The primary aim was intended to
determine what intensity of LTPA might be necessary to reduce CHE) risk in women
with MS. It was hypothesized that women reporting participation in increasing
intensities of LTPA would have more favorable CHD-risk factor profiles than women35
reporting no participation in LTPA. In addition, because physical activityrelated
improvements in the metabolic CHD risk factors are suggested to be mediated through
physical activityrelated reductions in total and abdominal fat, the present, cross-
sectional study evaluated whether the association between LTPA and the metabolic
CHD risk factors was independent from levels of total and abdominal fat in the sample
ofwomen with MS.36
METHODS
Official approval for the research project was granted by Oregon State
University, Corvallis; Rogue Valley Medical Center, Medford; and Oregon Health
Sciences University, Portland. The Institutional Review Board proposal is included in
appendix A. Data was collected from the MS clinic at Oregon Health Sciences
University, the Health and Human Performance Lab at Oregon State University, the
Asante Health Promotion offices at Rogue Valley Medical Center, the Springfield
Willamalane Senior Activity Center, the Three Rivers Hospital in Grants Pass, and the
Salem Hospital Rehabilitation Center. An informed consent was completed by each
participant prior to data collection. The informed consent form is included in appendix
B.
Women volunteers were recruited from Oregon MS chapters, physician
referrals, and newspaper announcements. Women with diagnosed cardiovascular
disease, insulin-treated diabetes, gout, or recently diagnosed thyroid disorder, and
women who currently used oral prednisone, smoked more than ten cigarettes per day, or
consumed more than four alcoholic beverages per day were excluded. Three women
were using cholesterol-lowering medications. Excluding these women from the present
analyses did not appreciably alter any of the results. All subjects had physician-
diagnosed MS.
Assessment of Lipids. Lipoprotein-Cholesterol. and Glucose
Venous blood (< 10 ml) was collected by venipuncture following a 12-hour fast
by trained lab technicians using sterile procedures. Firm pressure and a bandage was
applied to the venipuncture site immediately following blood collection. Serum and red
blood cells were separated by centrifugation at 1900 x g for 15 minutes. The serum was
transferred to plastic, labeled vials and frozen at _700 C for later analysis of
lipid/lipoprotem-cholesterol (total cholesterol, TG, HDL-C, and low-density
lipoprotein-cholesterol (LDL-C)) and glucose concentrations by Rogue Valley Medical
Center.37
Quality control of the Rogue Valley Medical Center laboratory is monitored by
the Lipid Standardization Program of the Centers for Disease Control and Prevention.
Measurements of lipid/lipoprotein-cholesterol and glucose were within specific limits
established by the Lipid Standardization Program of the Centers for Disease Control
and Prevention (i.e., 2.6 SD, 1.23% CV for total cholesterol; 2.3 SD, 1.4 1% CV for TG;
1.2 SD, 1.89% CV for HDL-C; and 1.2 SD, 3.26% CV for glucose).
Total cholesterol concentrations were determined by enzymatic procedures in
serum with cholesterol esterase, cholesterol oxidase, and peroxidase, which produce
colored products that are analyzed with spectrophotometers (125). TG concentrations
were determined by enzymatic procedures in serum with glycerol kinase,
glycerolphosphate oxidase, and peroxidase. Again, colored products produced are
spectrophometrically analyzed (125). HDL-C levels were determined using the direct
EZ-HDL Sigma assay, which uses anti human 9-lipoprotein antibody to bind with LDL,
VLDL, and chylomicrons. HDL-C levels can then be directly analyzed by enzymatic
procedures previously described for total cholesterol. High correlations are reported for
HDL-C levels between the Sigma method and standard enzymatic methods used alter
precipitation of beta lipoproteins with magnesiunildextran sulfate (r=0.98). Alter
directly measuring the concentrations of total cholesterol, TG, and HDL-C, LDL-C can
be calculated indirectly with the Friedwald equation (40):
LDL-C = Total cholesterol HDL-C TG/5
Glucose concentrations were determined by an oxygen rate method with a Beckman
Oxygen electrode. After adding glucose oxidase to the glucose sample, electronic
circuits measure the oxygen consumption rate, which is directly proportional to the
glucose concentration in the sample.
Because blood samples were initially going to be analyzed by Dr. Rosemary
Wander's Lipid Laboratory at Oregon State University, all samples were collected in
plasma EDTA tubes during the first week of testing. There was, however, an
unexpected early closure and relocation of Dr. Wander's Lipid Laboratory before all
blood samples could be collected. Although the laboratory at Rogue Valley Medical
Center agreed to analyze the blood samples for lipid/lipoprotein-cholesterol and glucose
concentrations, the laboratory was unable to accurately determine total cholesterol from38
samples collected in plasma EDTA tubes, estimating 24% bias. The majority of the
participants returned the following week to have their blood recollected in serum
separator tubes so that their total cholesterol levels could be analyzed by the Rogue
Valley Medical Center laboratory. Values for total cholesterol and LDL-C are missing
from nine subjects who participated in thestudyduring the first week of data collection
but were unable to return for a blood redraw. Because the methods used by the Rogue
Valley Medical Center laboratory could accurately determine levels of TG, HDL-C, and
glucose obtained in the plasma EDTA tubes, concentrations of TG, HDL-C, and
glucose from the nine subjects who did not return for a blood redraw were included in
the data analysis. We were unable to obtain blood samples from two subjects. Thus, all
measurements of lipid/lipoprotein-cholesterol and glucose are missing from these two
subjects. Finally, because the Friedwald equation, which is used to calculate LDL-C
from total cholesterol, HDL-C, and TG, is invalid when TG levels exceed 400 mg/dL,
LDL-C levels are missing from two subjects who had TG levels greater than 400
mg/dL.
Anthropometry for Assessment of Total and Abdominal Fat
Body weight was measured with a standard balance-beam scale in light clothing
without shoes at the Corvallis, Portland, Medford, and Grants Pass testing sites, and
with a digital scale at the Springfield and Salem testing sites. For participantswhowere
unable to stand, body weight was obtained on a chair scale when feasible. Three
participants were weighed on a chair scale. Weight was not obtained for five
nonambulatory participants. An estimate of weight for these five participants was
obtained from their physician. Height was measured without shoes using a stadiometer.
For participants tested at locationswhich lackeda stadiometer, and for participants who
were unable to stand, they were asked to contact their physician for their height.
Measurements (and estimates) of weight and height were used to calculate body mass
index.
Waist and hip circumferences were measured with a tape measure. Waist
circumference was measured at the narrowest portion of the torso between the top of the39
iliac crest and the lowest rib. Hip circwnference was measured at the level of the
greater trochanter. Continuous measurements of girth circumferences were conducted
in rotational order until measurements were within 1 cm agreement. For the
participants who were unable to stand, girth circumferences were measured ina
reclining position when feasible. The average of waist and hip circumferences within I
cm agreement were used to calculate the waist to hip ratio. The waist circumference
was used as the primaty index for abdominal obesity in the data analyses because it is
considered to be the most accurate anthropometric measure of abdominal and visceral
obesity (91).
Total body fat was calculated from multicomponent prediction equations using
skinfold thicknesses as an estimate of subcutaneous fat (127). Skinfold thicknesses
were measured with a Lange skinfold caliper at four sites on the right side of the body
(triceps, subscapular, abdomen, and calf) according to standardized procedures (49). To
reduce standing time for the participants, however, skinfold measurements for the
triceps, subscapular, and calf were obtained in a sitting position. Abdominal skinfold
measurements were obtained in a standing position. For the participants unable to
stand, abdominal skinfold measurements were obtained in a reclining position.
Continuous measurements of skinfold thicknesses were conducted in rotational order
until measurements for each site were within 1 mm agreement. Thesum of the 4
skinfold sites were used in the following multicomponent prediction equation for
women (127).
%BF = 0.428(swn skinfolds)-0.001 I (sum of skinfolds2)+0. 127(age)-3.O1
The multicomponent prediction equations used in the present studywere chosen
because 1.) they were developed on women between the ages of 34 and 84,2.) they
account for individual differences in the mineral and water components of fat free mass,
3.) they yield high multiple correlation coefficients between skinfold thicknesses and
body fat (ranging from 0.88 to 0.91) and small standard error estimates (ranging from
2.6 to 3.2), and 4.) they have been used previously in the literature to estimate body fat
specifically in women with MS (86).40
Physical Activity Assessment
The physical activity questionnaire used in the Postmenopausal
EstrogensIProgestins Intervention (PEPI) Study (42) was administered to assess
occupational, home, and leisure-time physical activity during the last 12 months.
Participants were asked to classify their intensity of occupational, home, and leisure-
time physical activity into inactive, light, moderate, and heavy categories based on the
examples provided. The criteria for intensity of physical activity is comparable to the
criteria for intensity of physical activity established by the Centers for Disease Control
and Prevention (82). A copy of the physical activity questionnaire from the PEPI Study
is included in appendix F.
Diet Composition
Eating habits and diet composition were assessed by the Block Food Frequency
Questionnaire (BFFQ). The BFFQ provides valid and reliable information regarding
dietary intake of total fat, saturated fat, and nutritional supplements (8). The BFFQ was
analyzed by Block Dietary Data Systems. A copy of the BFFQ is included in
appendix D.
Medical History
Because hormone replacement therapy (HRT) use, oral contraceptive use,
smoking history, alcohol consumption, and some medications are known to influence
the metabolic CHDriskfactors (36,109), a brief medical history questionnaire was
administered to obtain important information regarding medication use and personal
habits ofstudyparticipants in order to control for such potential confounders in the data
analysis. A brief mobility questionnaire (64) was included in the medical history
questionnaire to obtain information regarding the level of disability amongstudy
participants, so that the associations between physical disability and physical activity
practices could be examined. Physical disability ranged from a rating of 1 (I have no41
restriction on activities of normal employment or domestic life, but Iam not necessarily
symptom free) to a rating of 7 (I must be in bed all or most of the time). Acopy of the
medical history questionnaire is included in appendix E.
Statistics
Before running the statistical analysis, pairwise scatter plotswere made to assess
linearity, homoscedasticity, and the presence of outliers. Because the frequency
distribution of TG levels was skewed, TG levels were scaled using the natural log
transformation prior to running the statistical analyses. General linear modelswere
used to test for relationships between each physical activitymeasure and the selected
CHD riskfactors (abdominal circumference, TG, HDL-C, and glucose). Multivariable
models included age, HRT and oral contraceptive use, current and past cigaretteuse,
and alcohol consumption. The following general model was fit using the General
Linear Model Procedure in SAS (v6. 12) to each CHD risk factor:
CHDriskfactor = mu + betal (age) + beta2(HRT use) + beta3(oral contraceptive
use) + beta4(past cigarette use) + beta5(current cigarette use) + beta6(alcohol
use) + betal(physical activity2) + beta8(physical activity3) + beta9(physical
activity4) + episilon
where:
physical activity 2= light physical activity
physical activity 3 = moderate physical activity
physical activity 4heavy physical activity
CHI)riskfactor = abdominal circumference, TG, HDL-C, glucose
epsilon = error term
mu = intercept term
Age was a continuous variable. HRT and oral contraceptive use, current and
past cigarette use, alcohol use, and physical activity were categorical variables. All of
the noncontinuous variables were treated as categorical variables. All covariateswere
included into the model before adding physical activity. The four categorical physical
activity variables were regressed on the residuals from the model with just the
covanates known to influence the Cl-ID risk factors in order to account for unforeseen
relationships and to reduce problems arising from multicollinearity. Statistically42
significant F tests observed for the association between the CII]) risk factors and the
levels of physical activity indicated that the mean levels of the CHD risk factorswere
different across the different levels of physical activity after adjusting for the covariates.
The Fischer Protected Least Significant Difference procedurewas used to determine
which physical activity levels were different from each other while controlling for the
type I error rate (14).
For relationships that were significant between the physical activitymeasures
and the metabolic Clii)riskfactors after adjusting for the covariates, total body fat
(continuous variable) and waist circumference (continuous variable)were added as
covariates separately into the models to determine whether the associations between
physical activity and more favorable levels of the metabolic Clii)riskfactors were
influenced by lower amounts of total and abdominal fat. Dietary intake of fat
(continuous variable) was also added as a covariate into the original significant models
to determine whether differences in dietary intake of fat among participants influenced
the interpretations regarding the true association between physical activity and the
metabolic CH[)riskfactors.43
RESULTS
Table 2.1 shows that women reporting greater participation in higher intensity
LTPA during the last 12 months were more likely to adopt other health-related
behaviors, including significantly lower dietary intakes of total fat (p=0.01), marginally
lower dietary intakes of saturated fat (p=O.O6), significantly higher daily intakes of
vegetables (p=O.O3) and fruits (pO.008), and significantly greateruse of
multivitamin/antioxidant supplements (p=0.003). Mobility was inversely associated
with LTPA (p=0.001),totalbody fat (p=0.03) (data not shown), and waist
circumference (p=O.000 1) (data not shown), indicating that women with greater
mobility and less disability were more likely to participate in higher intensity LTPA and
were more likely to have lower amounts of total and abdominal fat. Cigarette and
antidepressant use were not related to LTPA.
Table 2.1: Relationship between Leisure-Time Physical Activity (LTPA) and
Age, Diet, Smoking, Alcohol, Medication Use, and Mobility in Participants.
Variable LTPA P Value
Age (yr's
Inactive
(n=19)
53.4
Light
(n=47)
50.7
Moderate
(n=40)
48.9
Heavy
(n=17)
45.8 0.01
Dietary Behaviors
TotalFatlntake(%) 35.7 34.0 33.9 28.4 0.01
Saturated Fat Intake (% 9.7 9.4 9.6 7.1 0.06
Vitamin Use (%' 58 81 82 100 0.003
Vegetable Intake (servings/dav 2.9 3.6 3.3 5.3 0.03
Fruit Intake (servings/day) 1.7 1.9 1.9 2.9 0.008
Cigarette Use
Current (<10/dav (%) 0 11 5 0 0.63
Past(% 37 43 25 24 0.16
Alcohol Intake (%) 5 32 35 41 0.02
Medication Use
Antidepressant (% 42 47 30 29 0.17
PostnienopausalHRT(% 37 50 48 35 0.84
Premenopausal OC (% 0 8.5 5 23.5 0.05
Mobility 4.5 2.2 1.5 1.3 0.001
HRT, Hormone Replacement Therapy
OC, Oral Contraceptive44
Table 2.2 shows that women reporting greater participation in higher intensity
physical activity had more favorable levels of adiposity for all indices of body
composition (i.e., body mass index, waist circumference, waist to hip ratio, and body
fat), significantly lower TG levels (p=O.0005), significantly lower glucose levels
(p=0.002), and marginally higher FIDL-C levels (p=O.O9). Work and home activity
during the last 12 months were not significantly associated with any of the CHD risk
factors.
Table 2.2: Mean Values for Adiposity, Lipids, Lipoprotein-Cholesterol, and
and Glucose by Intensity of Leisure-Time Physical Activity (LTPA).
Variable LTPA P-Value
Adiposity
Body Mass Index (kg/m2')±
Inactive
(n19)
30.4
Light
(n=47)
26.0
Moderate
(n=40)
26.0
Heavy
(n17)
23.1 0.002
Waist Circumference(cm* 92.6 82.7 80.4 74.8 0.0001
Waist to Hip Ratio** 0.80 0.76 0.75 0.75 0.004
BodyFat(%)* 41.3 37.6 37.2 30.8 0.0002
Metabolic Variables
Triglyceride (mg/dLfl 187.6 164.0 123.2 120.0 0.0005
HDL-C (mgldL)f 54.1 62.0 61.6 63.1 0.09
Glucose (mgjdL)t 100.9 91.4 90.9 88.4 0.002
Total Cholesterol (mg/dL)tt209.3 205.8 184.3 198.5 0.06
LDL-C (mg/dL)tt 117.7 109.4 98.5 112.5 0.27
HDL-C, High-density lipoprotein-cholesterol *N122 because of missing values
LDL-C, Low-density lipoprotein-cholesterol fN=121 because of missing values
N=120 because of missing values
**N1 18 because of missing values
ttN=1 12 because of missing values
After adjusting for age, HRT and oral contraceptive use, current and past
cigarette use, and alcohol intake, the relationship between LTPA and waist
circumference remained significant (p=0.01) (table 2.3) (figure 2.1). The mean waist
circumference for participants in the light (x8 1.1 cm), moderate (x=79 cm), and heavy
(x=74.2 cm) LTPA groups were significantly lower than the mean waist circumference
for participants in the inactive (x88.9 cm) LTPA group. Additionally, the mean waist45
circumference for participants in the heavy LTPA group was significantly lower than
the mean waist circumference for participants in the light LTPA group.
The inverse association between LTPA and TG levels remained significant after
adjusting for age, HRT and oral contraceptive use, current and past cigarette use, and
alcohol intake (table 2.3) (figure 2.1). The mean TG levels for women in the moderate
(x=134.4 mg/dL) and heavy (x=137.2 mg/dL) LTPA groups were significantly lower
than the mean TG level for women in the inactive (x=194.9) LTPA group.
Additionally, the mean TG level for participants in the moderate LTPA group was
significantly lower than the mean TO level for participants in the light (x169.6) LTPA
group. TO levels were positively associated with total body fat (p=O.00Ol) and waist
circumference (rO.000l). and marginally with dietary intake of fat (p=O.O7). The
statistically significant association between LTPA and TG levels was maintained after
including body fat (p=O.03) (table 2.4) and dietary intake of fat into the models (pO.O2)
(data not shown), but was lost when waist circumference was included into the model
(pO. 14) (table 2.5). The presented means for TG levels across the LTPA levels are not
log transformed.
The inverse association between LTPA and glucose levels remained significant
after adjusting for age, HRT and oral contraceptive use, current and past cigarette use,
and alcohol intake (p0.02) (table 2.3) (figure 2.1). The mean glucose levels for
women in the light (x=87.3 mgldL), moderate (x=86.4 mg/dL), and heavy (85.5 mg/dL)
LTPA groups were significantly lower than the mean glucose level for women in the
inactive (x=96.2 mg/dL) LTPA group. Glucose levels were positively associated with
total body fat (p'O.00Ol) and waist circumference (p=O.00O2), but not with dietary
intake of fat (p=O. 17). The statistically significant association between LTPA and
glucose was maintained after including total body fat (p=O.03) (table 2.4) and dietary
intake of fat into the model (p=O.O1) (data not shown), and was barely maintained after
including waist circumference into the model (p=O.O57) (table 2.5).
Although mean HDL-C levels appeared somewhat higher in those participating
in all intensities of LTPA relative to inactive participants, the standard deviations were
too large for the differences between the HDL-C means to be significant either before or
after adjusting for the covariates (table 2.3) (figure 2.1). Stratification ofpostmenopausal women based on HRT use, and stratification of premenopausal women
based on oral contraceptive use, did not alter the nonsignificant trend between physical
activity and HDL-C levels but almost became significant in premenopausal women not
using oral contraceptives (p0.08).
Table 2.3: Adjusted Mean WC, TG, Glucose, and HDL-C by Intensity of Leisure-
Time Physical Activity (LTPA).
Adjusted MeanAdjusted MeanAdjusted MeanAdjusted Mean
LTPA WC(cm)*TGmg/dL)tGlucose(mg/dL)tHDL-C(mgldL't
p'O.Ol p0.O1 p0.02 p=O.5
Inactive (n=19)88.9 194.9 96.2 60.7_
Light (n47) 81.lt 169.6 87.3t 66.lt
Moderate (n=40)79.O 134.4th 86.4 65.9
Heavy (n=17) 74.21J 137.2 85.5 66.5
WC, Waist Circumference; TG, Triglyceride; HDL-C, High-Density Lipoprotein
Cholesterol
*N122 because of missing values
tN=121 because of missing values
Adjusted for age, hormone replacement therapy and oral contraceptive use, current and
past cigarette use, and alcohol consumption.
P-values shown underneath the CHD risk factors are for overall F test.
All other p-values are for contrasts of least-squares means estimates.
Type I comparison error rate was controlled by the Protected Least Significant
Difference Procedure.
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Figure 21: Waist Circumference, TriglycerideLevels, Glucose
Levels, and High-Density Lipoprotein-Cholesterol(HDL-C) Levels
According to the Intensity of Physical Activityduring the Last
12 Months
P-values represent the overall F test for the relationshipbetween the
CHD risk factors and intensity of physicalactivity during the last
12 months (LTPA), with adjustment forage, hormone replacement
therapy and oral contraceptiveuse, current and past cigarette use,
and alcohol intake. All other p-valuesare for contrasts of least-
squares means estimates: * indicates pO.O5 for comparison with
the inactive category;* indicates pO.O5 forcomparison with the
light category. Type 1 comparisonerror rate was controlled by
Protected Least Significant Difference.48
Table 2.4: Adjusted Mean TO, Glucose, and HDL-C by Intensity of Leisure-
Time Physical Activity (LTPA)
Adjusted Mean Adjusted MeanAdjusted Mean
LTPA TG (mg/dL')f Glucose (mg/dL)tHDL-C (mg/dL)t
p0.03 p=O.03 p=O.58
Inactive (n=:19 188.8 95.9 60.9_
Light (n=47) 170.6 87.3t 66.1
Moderate (n=40)136.0th 86.4 65.9
Heavy (n=n17) 160.5th! 86.4t 65.6t
TO, Triglyceride; HDL-C, High-Density Lipoprotein-Cholesterol
tN121 because of missing values
Adjusted for age, hormone replacement therapy and oral contraceptiveuse, current and
past cigarette use, alcohol consumption, and body fat.
P-values shown underneath the CHD risk factors are for overall F test.
All other p-values are for contrasts of least-squaresmeans estimates.
Type 1 comparison error rate was controlled by the Protected Least Significant Difference
Procedure.
p<0.OS vs. inactive, ¶pO.O5 vs.light
Table 2.5: Adjusted Mean TG, Glucose, and HDL-C by Intensity of Leisure-
Time Physical Activity (LTPA)
Adjusted Mean Adjusted MeanAdjusted Mean
LTPA TG (mg/dL')t Glucose (mg/dL)tHDL-C (mg/dL)t
p=0.14 p=O.O57 p0.82
Inactive (n=19) 212.2 100.8 60.6
Light (n47) 184.9 92.8 64.1
Moderate (n40) 157.8th! 92.4 63.4
Heavy (n17) 170.4th! 92.6t 62.7t
TO, Triglyceride; HDL-C, High-Density Lipoprotein-Cholesterol
tN=121 because of missmg values
Adjusted for age, hormone replacement therapy and oral contraceptiveuse, current and
past cigarette use, alcohol consumption, and waist circumference.
P-values shown underneath the CR])riskfactors are for overall F test.
All other p-values are for contrasts of least-squaresmeans estimates.
Type I comparison error rate was controlled by the Protected Least Significant Difference
Procedure.
p<zO.05 vs. inactive, lp<O.05 vs.light49
DISCUSSION
This study showed that intensity of LTPA over the pastyear was related to less
abdominal fat accumulation, lower levels of fasting TG and glucose, and marginally
with higher levels of fasting HDL-C in a sample ofwomen with MS. Although it is
undisputed that physical activity contributes to important health benefits, theexact
amount and intensity of physical activity required to achieve these health benefits is
unclear. The findings suggest that all intensities of LTPA (light, moderate, heavy)are
significantly associated with reduced CHDriskin women with MS. In this regard,
significantly lower waist circumferences, TG levels, and glucose levels, and marginally
higher HDL-C levels were observed in women reporting participation in light-to
moderate-intensity LTPA relative to their sedentary counterparts. Moving fromlightto
moderate or heavy forms of LTPA conveyed additional benefits with respectto waist
circumference and TO levels. Adjusting for the covariates (age, HRT and oral
contraceptive use, current and past cigarette use, and alcohol intake) slightly attenuated
the significant association between LTPA and waist circumference, TG levels, and
glucose levels, but the significant trends and overall statistical significancewas
maintained.
More favorable levels of adiposity were observed with each increase in intensity
of LTPA. This suggests that reductions in adiposityaccrue with greater participation in
increasing intensity of physical activity. Still, the greatest magnitude of difference in
body mass index, waist circumference, and the waist to hip ratiowas evident between
women reporting participation in light-intensity LTPA and women reporting no
participation in LTPA. Although interpretations are limited by the cross-sectional
design of the present study, the significant associations between LTPA and all indices
of total and abdominal adiposity suggest that physical activitymay be an effective
means for lowering total and abdominal fat.
Greater amounts of abdominal fat are consistently reported to be associated with
higher levels of fasting TO (13,25) and glucose (65), and lower levels of fasting HDL-C
(13,17,25). Our data agree with these observations in that waist circumferencewas
associated with each of the selected metabolic CHD risk factors (TG, glucose, andHDL-C). Reductions in physical activity andenergy expenditure are believed to
contribute to abdominal fat accumulation (21), which in turn is believedto precede and
be largely responsible for increases in circulating levels of TG and glucose,and
decreases in circulating levels of HDL-C (21,24). In the present sample ofwomen with
MS, waist circumference was significantly inversely associated with LTPA.Although
the lowest waist circumferences were observed inwomen reporting heavy-intensity
LTPA, women reporting regular participation in light- and moderate-intensityLTPA
had significantly lower waist circumferences than those reportingno participation in
LTPA. Similarly, low-intensity physical activity has been shownto be associated with
lower waist circumferences in older adults (85) and viscerally obese olderadults (84).
The current recommendations from the National Cholesterol Education Program
(36), which encourage physical activityas an effective means for lowering TG levels,
are validated by evidence from several observational and training studies demonstrating
an inverse association between physical activity and TG levels (7,3 1,132,133). In this
study, women reporting moderate- and heavy-intensity LTPA had significantlylower
TO levels compared with women reportingno LTPA, and women reporting moderate-
intensity LTPA had significantly lower TO levels compared withwomen reporting
light-intensity LTPA. The more favorable levels of TO with physical activityare
believed to be primarily mediated throughan exercise-induced increase in lipoprotein
lipase activity that facilitates TO breakdown within circulating chylomicronsand very
low-density lipoproteins (10,31,41).
Women reporting participation in any intensity of LTPA had significantly lower
glucose levels relative to women reportingno participation in LTPA. The lower
glucose levels observed in women participating in either light, moderate,or heavy
LTPA suggest that physically activewomen with MS have improved insulin sensitivity
and glucose tolerance. Furthermore, an improved insulin sensitivitymay be
mechanistically linked with the lower TO levels observed in thepresent sample of
active women, by its association with greater lipoprotein lipase activity (7,43).Our
results support findings from the Insulin Resistance AtherosclerosisStudy (69), a large
cross-sectional study, which observed greater insulin sensitivityamong nonvigorously
active men and women relative to their inactive counterparts, and findings fromthe51
Nurses Health Study (51), a large prospective study, which observed an inverse
association between nonvigorous physical activity and the development of noninsulin
dependent diabetes mellitus (NIDDM) in female nurses. In the Insulin Resistance
Atherosclerosis Study and the Nurses Health Study, however, moderate- to vigorous-
intensity physical activity conferred even greater benefits with respect to insulin
sensitivity and NTDDM risk, respectively, than lower-intensity physical activity. By
contrast, the present study observed that active women with MS had similar levels of
glucose independent from the intensity by which their activity was performed.
The observation that even low-intensity physical activity was associated with
lower glucose levels in our participants is consistent with other cross-sectional data
which demonstrate that the greatest difference in glucose levels in normal weight older
adults (85) and viscerally obese older adults (84) occurred between those reporting
participation in light-intensity physical activity related to daily living and those
reporting little or no participation in light-intensity physical activity related to daily
living.
Higher levels of HDL-C are frequently observed in physically active individuals
(31,32,128,131) relative to physically inactive individuals (31,32,128,131). The
association between physical activity and HDL-C levels is most consistent among men,
however, because men typically have lower FIDL-C levels relative to women, and
therefore, their }{DL-C levels have more room to rise with physical activity. Some
cross-sectional studies report a dose-response relationship between increasing levels of
physical activity and increasing levels of HDL-C in women (32,128), and some training
studies have identified that low- to moderate-intensity physical activity can raise HDL-
C levels similar to vigorous-intensity physical activity when controlling for energy
expenditure (29,45,60). In the present study, a marginally significant association was
observed between HDL-C levels and LTPA. After adjusting for the covariates, mean
levels of HDL-C were observed to be somewhat higher in women participating in all
intensities of LTPA relative to inactive women, but the standard deviations were too
large for the overall trend between HDL-C levels and LTPA to be significant
The absence of an overall significant association between HDL-C levels and
LTPA after adjusting for the covariates in this study has been previously observed in52
premenopausal women (12,68,116,128,137) and postmenopausal women using HRT
(66,110). For instance, physical activity was not associated with higher HDL-C levels
in premenopausal runners using oral contraceptives (128), in premenopausal women
using oral contraceptives following ten weeks of aerobic exercise training (137), in
premenopausal women using and not using oral contraceptives following four months
of aerobic exercise training (116), nor in premenopausal women not using oral
contraceptives following ten weeks of aerobic exercise (12). Moreover, a meta-analysis
examining the effects of physical activity on HDL-C levels in premenopausal women
found no significant increases in HDL-C when compiling data from 27 exercise training
studies (68). Lindheim et al. (66) observed no differences in HDL-C levels between
postrnenopausal women receiving HRT and postmenopausal women receiving HRT
with exercise intervention, such that physical activity offered no additional benefit in
raising HDL-C levels above that achieved with HRT alone. Furthermore, no significant
increases in HDL-C levels were observed following a one-year exercise training study
in postmenopausal women exercisers using and not using HRT (110).
The lack of a significant physical activityrelated increase in HDL-C levels
among premenopausal women and posttnenopausal women using HRT may be
attributed to the strong influence that premenopausal endogenous estrogen and
postmenopausal HRT have on raising HDL-C levels (15,52,136), which limits the
extent by which HDL-C levels can rise with physical activity. In our study, 40% of the
participants were premenopausal and 74% of the postmenopausal participants were
using HRT. Because endogenous estrogen declines following menopause, physical
activity may be most effective in raising HDL-C levels in postmenopausal women not
using HRT (60,128). In fact, physical activity may attenuate, and perhaps eliminate, the
reductions in HDL-C levels that frequently occur after menopause (46). However, only
25% of the postmenopausal women in the present sample (n=49) were not using HRT.
Therefore, we lacked power to determine whether physical activity and HDL-C levels
were related in postmenopausal women not using HRT. Still, Kiebanoff et al. (62)
found no significant increases in HDL-C levels in response to 12 weeks of exercise
training in either postmenopausal women using HRT or postmenopausal women not
using HRT.53
The intensity of home and work activity over the previous yearwas not
associated with any of the selected CHD risk factors. Because the physical activity
questionnaire used in the present study was based on recall, and because leisure-time
fonns of physical activity may be more easily recalled than activities suchas
housework, the inability to find a significant relationship between home activity and
reductions in CHD risk may reflect the imprecision or inaccuracy of classification into
home activities based on self-report. Furthermore, many of the participants who
engaged in moderate to heavy forms of LTPA reported little or no home-related forms
of physical activity. The majority of work activity engaged in by employed participants
(42%) fell primarily into the intensity categories of inactive and light, whichmay
explain the absence of significant linear associations between work activity and the
CHD risk factors.
Another question addressed in the cunent study was whether the addition of
either total body fat, waist circumference (as a measure of abdominal fat accumulation),
or dietary intake of fat in the multivariate models would attenuate or eliminate the
significant association between LTPA and the metabolic CHDriskfactors. Although
BMT is most frequently used as a measure of adiposity (97,128,136), BMI is limited in
its ability to accurately represent levels of adiposity because it does not distinguish
between excess weight for height from fat mass and excess weight for height from fat
free mass. Thus, total body fat was used as the measure of adiposity in the regression
models.
The rationale for including total body fat and abdominal fat measurements in the
multivariate models is based on research which suggests that favorable levels of the
metabolic CHDriskfactors observed in physically active persons are mediated largely
by lesstotalbody and abdominal fat accumulation also observed in physically active
persons (27,29,132,133,134). By contrast, some evidence suggests that physical
activityrelated improvements in the metabolic CHDriskfactors are primarily mediated
by physical activityinduced increases in lipoprotein lipase activity that mayoccur
independently from total body and abdominal fat loss (59,67,126). Our datasupportthe
operation of both pathways in that the significant association between LTPA and levels
of TO and glucose was attenuated when adding total body fat in the multivariate model,54
but significant trends and overall statistical significancewas maintained. This suggests
that lower levels of total body fat observed in physicallyactive women with MS are
partly, but not entirely, responsible for the lower levels ofTG and glucose also observed
in physically active women with MS.
When including waIst circumference into the multivariatemodels, however, the
significant association between LTPA and levels of TGwas lost, and the significant
association between LTPA and levels of glucosewas marginally maintained. These
findings suggest that abdominal fat actsas a stronger biological modulator in the causal
pathway between physical activity and levels of TG andglucose than body fat, and
therefore, explains more of the association between physicalactivity and levels of TG
and glucose than body fat. The greater attenuation, andeven loss of statistical
significance when waist circumference is added into the multivanatemodel, emphasizes
the importance of maintaining and preventingage- and physical inactivityrelated
increases in abdominal fat accumulation.
Although body fat and abdominal fatmay act as biological mechanisms in the
association between the metabolic CIII) risk factors and physicalactivity, dietary intake
of fat may act as a confounder in this association. Significantassociations between
LTPA and levels of TG and glucosewere maintained after including dietary intake of
fat into the multivanate model, which supports the independentinfluence that physical
activity has on the metabolic CHD risk factors.
In summary, the results from this study show that exerciselevels attainable by
women with MS were associated with more favorable levels of adiposity andmore
favorable levels of some of the metabolic CHDriskfactors, including lower levels of
TG and glucose, and perhaps tosome extent, higher levels of HDL-C. Current physical
activity recommendations emphasize frequent participationin moderate-intensity
physical activity accumulating at least 30 minutes each day. Theunderlying rationale
for the current physical activity recommendations is basedon research which suggests
that frequent bouts of low- to moderate-intensity physicalactivity can lower CHDrisk
similar to a single, longer bout of high-intensity physicalactivity (2,30,29,54,73,123).
Our findings lend support to the current physical activityrecommendations by
demonstrating that most of the benefit associated with physicalactivity was accounted55
for by comparing the most inactivewomen with MS to those who participated in light-
to moderate-intensity LTPA. The observation thateven low-intensity LTPA was
significantly associated with lower CHD risk is particularly encouragingfor women
with MS, who may not be able to realistically participate in high-intensityphysical
activity due to the limitations imposed by their disability.56
Several studies have shown that the sensory and motor impairments of MS,
including fatigue, weakness, ataxia, spasticity, heat intolerance, balance problems,
blurred vision, pain, and loss of bladder and bowel control, can profoundly interfere with
and limit the extent by which many women with MS can effectively and consistently
incorporate health promotion practices into their daily lives (113,114,115). Because
health behaviors, including physical activity and dietary habits, can influence the risk for
CHD by their association with total body and abdominal fat accumulation, insulin
sensitivity, and levels of lipids and lipoproteins, the aim of the first manuscriptwas to
examine CHD risk in women with MS by comparing the frequency of inactivity and the
frequency of anthropometric, dietary, and metabolic CHD risk factors between the
present sample of women with MS and the general population of women participating in
the BRFSS, NETS, and N}{A}4E5 ifi.
Because physical activity practices are reported to be low in women with MS
(76,80,90,119), it was originally hypothesized that the majority of the women with MS
volunteering for this study would be physically inactive, yet 65% of the participants met
the LTPA recommendations described in the 1996 BRFSS by regular participation in
light- to moderate-intensity LTPA accumulating at least 30 minutes on at least fivedays
of the week. The most frequently reported activities were gardening, leisurely walking,
and stretching. Some women (10.6%) regularly participated in 20 minutes of vigorous-
intensity LTPA on at least threedaysof the week. Because the majority of participants
were ambulatory (85.4%) and because more active and health-conscious women are more
likely to volunteer for a health behaviorstudysuch as this, the large proportion of women
reporting LTPA in this study is probably not representative of the total population of
women with MS. Still, the high prevalence of physically active behaviors among our
participants provides promising evidence that women with MS can remain physically
active "within the context of their disability (114)."
Despite the high participation in LTPA, women with MS in this sample were at
similar CHD risk as the general population of women without MS with respect to body
composition and levels of TG and HDL-C. Although more active women with MSadopted better dietary habits, including less dietary intakes of total and saturated fat, and
higher dietary intakes of fruits and vegetables, 69% of participants exceeded the
recommended intakes of dietary fat, and slightly less than half met current dietary
recommendations for daily fruit and vegetable intake. It is possible that the high
consumption of total fat and low consumption of fruits and vegetablesamong the
majority of study participants may have interfered withsome of the positive effects that
physical activity had on improving CHD risk, andmay be partly responsible for the
frequency of the anthropometric and metabolic CH1) risk factors observed in this sample.
Postmenopausal women using HRT and premenopausalwomen using oral
contraceptives, however, did have more favorable metabolic CFID risk factor profiles
relative to postmenopausal and premenopausalwomen not using hormones.
Because physical activity is known to substantially reduce CHI) risk by its
association with less total body and abdominal fat accumulation, lower levels of TG,
higher levels of HDL-C, and improved insulin sensitivity, the aim of the second
manuscript was to determine what intensity of LTPA might benecessary to improve
CHD risk in women with MS with respect to the anthropometric and metabolic CR1)risk
factors. Findings from the second manuscript show that all intensities of LTPA (light,
moderate, and heavy) were significantly associated with reduced CHI) risk inwomen
with MS. Significantly less total body and abdominal fat accumulation, significantly
lower levels of TO and glucose, and marginally higher levels of HDL-Cwere observed in
women with MS reporting participation in light- to moderate-intensity LTPA relative to
inactive women with MS. The significant associations between LTPA and abdominalfat
accumulation and levels of TG and glucose were maintained after adjusting for several
covariates known to influence the CHD risk factors.
Lower amounts of total body and abdominal fat accumulation observed in
physically active individuals are suggested to actas biological modulators responsible for
the more favorable levels of the metabolic CHD risk factors observed in physically active
individuals (27,29,132,133,134). It is often argued that the inclusion of either total body
fat or abdominal fatintomultiple regression models that attempt to examine the
association between physical activity and the metabolic CR1) risk factors results ina
statistical overcorrection that ultimately underestimates the benefits of physical activity58
(42,51). In this study, the significant associations between LTPA and levels of TG and
glucose were maintained after including total body fat in the multivariate models, but the
significant association between LTPA and TG was lost and the significant association
between LTPA and glucose was marginally maintained after including waist
circumference in the multivanate models. These results suggest that abdominal fat
accumulation is a stronger biological modulator in the causal pathway between physical
activity and levels of TG and glucose than total body fat. The observation that more
favorable levels of TG and glucose observed in physically active women with MS were
mediated in large part through less abdominal fat accumulation also observed in
physically active women with MS does not detract from the importance that physical
activity has on improving CHD risk Rather, these findings emphasize the role that
physical activity plays in reducing abdominal fat accumulation and ameliorating its
associated metabolic and hormonal disturbances.
Current physical activity recommendations, which emphasize at least 30 minutes
of moderate-intensity physical activity on most days of the week, are based on research
which suggest that low- to moderate-intensity physical activity can lower CHDrisk
similar to high-intensity physical activity (2,29,30,54,60,73,82,123). The fmdings from
the second manuscript lend support to several studies that have provided the underlying
rationale for the current physical activity recommendations by demonstrating that 1.)
light- to moderate-intensity LTPA improved CHDriskby its significant associations with
less abdominal fat accumulation, lower levels of TG and glucose, and perhaps tosome
extent, higher levels of HDL-C, and 2.) most of the benefit associated with physical
activity was accounted for by comparing the most inactive women with MS to those who
reported participation in light- to moderate-intensity LTPA. Thus, low- to moderate-
intensity physical activity may be an effective and attainable strategy for reducing CHD
risk in women with MS.
It is our hope that physicianswillincorporate these findings into their
understanding of the importance that any physical activity can have on improving health
and CHDriskin women with MS. We hope that our findingswillhelp to attenuate some
of the perceived barriers that frequently prohibit women with MS from participating in
traditional, structured exercise programs, and to convince health care professionals toinclude light- to moderate- intensity physical activity prescription into their existing
treatment of women with MS. Our results clearly show that even low-intensity physical
activity is significantly associated with improved C}{D risk and may contribute to
important health-related benefits in women with MS. Thus, the present findings are
particularly encouraging for women with MS, who may not be able to realistically engage
in high-intensity physical activity due to the limitations imposed by their disability.BIBLIOGRAPHY
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APPENDIX A
INSTITUTIONAL REVIEW BOARD PROPOSAL74
OSU Institutional Review Board (IRB)
Differences in Coronary Heart Disease Risk Factors between
Active and Inactive Women with Multiple Sclerosis
Application for Approval of the OSU Institutional Review Board (IRB)
For the protection of Human Subjects
1.Significance of the Project.
Women are twice as likely to develop multiple sclerosis (MS) than men. The majority
of women with MS will live at least 90% of a full life span. However, because women
with MS frequently have low participation in physically active behaviors and because
physical inactivity is designated as a major coronary heart disease (CHD) risk factor,
women with MS may be at increased risk for CHD as they age. In fact, physically
inactive individuals are 1.5 to 2.4 times more likely to develop CHD relative to their
physically active counterparts.
Physical inactivity raises CHI) risk, in part, by its association with abdominal fat gain,
high circulating levels of triglycerides (TG), and low circulating levels of high density
lipoprotein-cholesterol (HDL-C). High levels of TG and low levels of BDL-C are
strong, independent, metabolic predictors of CHD risk in women. Furthermore, age-
related reductions in physical activity contribute to age-related gains in abdominal tht,
which in turn, is associated with, and may be the initial defect contributing to increases
in circulating levels of TG and reductions in circulating levels of HDL-C in women.
The United States Surgeon General emphasizes the need for research focusing on
preventative measures for reducing CHD risk, specifically in women and those with
disabilities. Because physical activity substantially reduces CHD risk, in large part, by
its association with low amounts of abdominal fat, low circulating levels of TG, and
high circulating levels of HDL-C, the primary aim of the proposed study is to determine
whether levels of abdominal fat, TG, and HDL-C differ between active and inactive
women with M. The primary aim is intended to determine whether more active women
with MS are at lower CHD risk than less active women with MS. Furthermore, the
primary aim may provide valuable information for establishing preliminary physical
activity guidelines for reducing CR1) risk in women with MS.
2. Methods and Procedures.
The proposed study is a cross-sectional study examining the differences in CR1)risk
factors between active and inactive women with MS. Datawillbe collected at the
Health and Human Performance Lab at Oregon State UniversityinCorvallis, the Rogue
Valley Medical Center in Medford, the Willamalane Senior Center in Springfield, the
Salem Rehabilitation Center in Salem, and the Multiple Sclerosis Clinic in Portland.75
Data collection from testing sites will require approximately 4 months to complete.
Trained undergraduate seniors and graduate students will assist with data collection.
Data collection for each subject will require no more than 2.0 hours to obtain. During
the lab visit 1.) venous blood will be collected for measurement of lipid and
lipoprotein-cholesterol levels (total cholesterol (TC), TG, low-density lipoprotein-
cholesterol (LDL-C), and HDL-C); 2.) skinfold thicknesses and girth circumferences
will be obtained for estimation of total and abdominal body fat; and 3.) information
regarding physical activity, dietary habits and composition, and medical histoiywillbe
obtained by interviewer- and self-administered questionnaires. The data collected from
the physical activity, dietary composition, and medical history questionnaireswillbe
used to estimate the extent by which overall health behavior differences may contribute
to CELl) metabolicriskfactors in women with MS.
Blood Collection
Venous blood (<20 millimeters)willbe collected by venipuncture following a 12-hour
fast by a trained technician using sterile procedures. Firm pressure anda bandagewill
be applied to the venipuncture site immediately following the blood draw.
Approximately 10 to 15 minutes is required to collect the blood samples for each
person. Plasma and red blood cells will be separated by centrifugation at 1900 x g for
15 minutes. The plasmawillbe transferred to plastic labeled vials and frozen at 70C
for later analysis of lipid and lipoprotein-cholesterol concentrations.
Assessment of Lipids and LipoDroteins
Lipid and lipoprotein cholesterol levels (TC, TG, LDL-C, and HDL-C)willbe
measured by Rosemary Wander, Ph.D., in the Lipids Laboratory in the Department of
Nutrition and Food Management at Oregon State University. Quality control of Dr.
Rosemaiy Wander's laboratory is monitored by the Lipid Standardization Program of
the Centers for Disease Control and Prevention. TC, TO, and HDL-Cwillbe directly
measured by enzymatic procedures. LDL-Cwillbe calculated indirectly from the direct
measurements of TC, TG, and HDL-C.
Anthropometry for Assessment of Total and Abdominal Body Fat
Body weightwillbe measured with a standard balance-beam scaleinlight clothing
without shoes. Heightwillalso be measuredwithoutshoes using a stadiometer. Total
body fatwillbe calculated from equations using skinfold thicknesses as an estimate of
subcutaneous fat. Skinlold thicknesses will be measured with a Lange skinfold caliper
at 4 sites on the right side of the body (triceps, subscapular, abdominal, and call) by a
trainedlab assistant according to standardized procedures. Because it is undetermined
whether more favorable blood levels of TG and HDL-C observed in physically active
individuals is independent from lower amounts of total body fat also observed in
physically active individuals, the proposed study will determine whether the associationbetween physical activity and blood levels of TG and HDL-Care independent from
total body fat in the study sample ofwomen with MS.
Waist and hip circumferences will be measured witha tape measure. Waist
circumference and the waist to hip ratio will be usedas an index for abdominal obesity
in the data analysis. Recent evidence suggests that the waistcircumference may be the
most accurate anthropometric measure of abdominal and intra-abdominal obesity.
Because abdominal fat gain may proceed the onset of the CHD metabolic riskfactors,
the proposed studywillquantify the association between increasing amounts of
abdominal fat and increasing levels of blood TG, and between increasingamounts of
abdominal fat and decreasing levels of blood HDL-C in studyparticipants.
Approximately 20 minutes is required to obtain the skinfold thicknessesand girth
circumferences for assessment of total and abdominal fat.
Physical Activity Assessment
The Yale Physical Activity Survey (YPAS)willbe used as an unobtrusive means for
assessing physical activity levels of the study participants. Because theYPAS accounts
for lower-intensity, home-related activities and other activitiesrelated to daily living,
the YPAS is the most appropriate measurement tool available forestimating physical
activity in women with MS. During the administration of the YPAS,subjects are asked
to respond to interviewer-administered questions regarding their participationin
common home- and yard-related activities, exercise- and recreational-related activities,
and daily living-related activities. The YPAS isa valid and reliable measurement tool
requiring 20-30 minutes to administer.
A brief 12-month physical activity questionnaire used in thePostmenopausal
EstrogenslProgestms Intervention (PEPI) Studywillbe administered during the initial
eligibility telephone screening interview toassess occupational, home, and leisure-time
physical activity over the entire year. The information obtained fromthe PEPI Physical
Activity Questionnairewillstratify the women volunteers into various activity levels
prior to actualdatacollection so that equal representation of moderately physically
active women with MS, lightly physically activewomen with MS, and physically
inactive women with MS will be achieved. Administration of thePEPI Physical
Activity Questionnaire will take approximately 5 minutes.
Diet Composition
Eating habits and diet compositionwillbe assessed by the self-administered Block Food
Frequency Questionnaire. The Block Food Frequency Questionnaireprovides valid and
reliable infonnation regarding dietary intake of total fat, saturated fat,cholesterol,fiber,
and nutritional supplements. Because high saturated fat and cholesterolintake
substantially raises CHD risk, and becausesome evidence suggests that high saturated
fat intake is linked with an increase in the frequency andseverity of exacerbations, and
overall deterioration associated with MS, the inclusion ofa dietary analysis is necessary
to determine the extent of dietary intake of saturated fat and cholesterolamong study77
participants. Because antioxidant nutritional supplement use reduces CHD risk, the
quantification of dietary intake of supplements is necessary to control for the
confounding influence of antioxidant use in the data analysis. Moreover, because low-
fat diets are associated with high TG levels and low Hl)L-C levels, an appropriate
dietary analysis is necessary to consider how potential differencesintotal fat intake
among study participants may confound the interpretations regarding the true
association between physical activity and circulating levels of TG and HDL-C. The
Block Food Frequency Questionnaire requires approximately 30-40 minutes to
complete.
Medical History
Because hormone replacement therapy (HRT) use, smoking history, alcohol
consumption, and some medications are known to influence the CHD metabolic risk
factors, a brief medical history questionnairewillbe administered to obtain important
information regarding personal habits, previous and current HRT use, and lipid and
lipoprotein-cholesterol altering medications of study participants in order to control for
such potential conlounders in the data analysis. In addition, because health promotion
practices frequently decline with increasing disability associated with the complications
of MS, the medical history questionnaire will obtain information regarding mobility
levels among study participants in order to quantify the association between the
metabolic CHD risk factors and the seventy of MS. The medical history questionnaire
willrequire approximately 10 minutes to complete.
Data Analysis
Analysis of covariancewillbe used to determine whether the selected CHD risk factors
(abdominal fat, TG, and HDL-C) differ between active and inactive women with MS
alter adjusting for age, lipid and lipoprotein-cholesterol altering medication use, and
HRT use. Logistic regression will be performed to quantify the relationship between
the selected CHD risk factors on the log odds of the probability of having severe MS
unadjusted and adjusted for age, lipid and lipoprotein-cholesterol altering medication
use, and HRT use. To quantify the association between abdominal fat and TG, and
between abdominal fat and HDL-C, separate multiple linear regressions will be
performed after adjusting for the effects of age, lipid and lipoprotein-cholesterol altering
medication use, and HRT use. To determine whether the association between physical
activity and circulating levels of TG and HDL-C is independent from total body fat,
multivariate linear regression will be performed.
3. Benefits and Risks.
Benefits
Subjects participating in the studywillreceive information regarding their: 1.) lipid and
lipoprotein-cholesterol profile, and current recommendations from the National
Cholesterol Education Program and the Lipid Clinics' Follow-up Study to help them78
interpret and understand their test results; 2.) dietary intake of total fat, saturated fat,
cholesterol, sodium, fiber, and antioxidants, and current recommendations from the
American Dietetics Association to help them understand their dietary assessment; 3.)
total and abdominal fat measurements, and comparisons to national normative values
and to values associated with increased health risks for women; and 4.) total
accumulated time spent in physically active behaviors duringa typical week, and
recommendations from the United States Surgeon General regarding how much
physical activity may be necessary to achieve health-related benefits.
Risks
Some discomfort and minor bruising may occur during the blood draw. To minimize
discomfort and the risk of infection, sterile procedures during the blood collection will
be used by a trained technician, and firm pressure and a bandage will beappliedto the
vempuncture site following the blood draw.
Minor discomfort may be associated with the skinfold measurements from the pinching
of the skin with the skinfold calipers. Discomfort will be minimized by having
experienced lab assistants conduct the skinfold measurements according to standardized
procedures to reduce the time necessary to achieve accurate measurements.
The physical activity, dietary assessment, and medical history questionnairesmay seem
tedious. Fatigue related to completing the questionnaires will be minimized by
measuring total and abdominal body fat, and providing a snack between administration
of questionnaires.
4. Subject Population.
Approximately 100 volunteers for the proposed studywillbe recruited from Oregon MS
chapters, physician referrals, and existing databases developed from previous studies
involving women volunteers with MS at Oregon State University who have agreed to be
contacted for future studies. Physicians from the Medford Neurological and Spine
Clinic and physicians on the Institutional Review Board at Rogue Valley Medical
Center have agreed to discuss the proposed study with their MS patients during their
office visits. Patients interested in participating in the proposed studywillbe given
Jennifer Slawta's phone number for further information regarding the study. In
addition, Jennifer Slawta will present the study at Oregon self-help meetings for
recruitment of interested participants. Because MS affects twice as manywomen than
men and because the United States Surgeon General emphasizes the need for research
addressing preventative measures for reducing CHD risk inwomen and persons with
disabilities, subjects recruited for the proposed studywillbe exclusively women with
MS. Women with cardiovascular disease, diabetes, or gout, women who currently
smoke more than 10 cigarettes per day or consume more than 4 alcoholic beveragesper
day, and women currently using thyroid, corticosteroid, or gout medications, will not be
recruited for participation in the proposed study. Although 95% of the MS population
is Caucasian, there are no ethnic restrictions for participation in the proposed study.79
Subject recruitment for the proposed study will be aimed to achieve equal
representation in each of 3 activity groups as defined by the PEPI Physical Activity
Questionnaire including moderately physically active women with MS, lightly
physically active women with MS, and physically inactivewomen with MS. Physically
active women volunteers with MS will be recruited from existing databases developed
from previous and ongoing MS training studies in the Health and Human Performance
Department at Oregon State University. The majority of physically inactivewomen
volunteers with MSwillbe recruited from the AshlandfMedford area.
5. Informed Consent Document.
A copy of the informed consent for the proposed study is attached.
6. Methods by which the informed consent will be obtained.
Participants will be asked to read and sign the informed consent prior to their
participation in the proposed study. Participantswillbe informed of their right to
withdraw from thestudyat any time without prejudice. Any questions regarding the
proposed study, testing procedures, or any other subjectconcerns,willbe answered by
the principal investigator or, if appropriate, the research staff.
7. Method by which subject confidentiality will be maintained.
Subject information will only be available to the researcher and research staff of the
proposedstudy.Subject's identitywillremain anonymous in thestudyresults by the
use of identification numbers instead of names in the data entry and analysis. A data
file will be created to link subjects' identity (names, addresses, and phone numbers)
with the data in order to send participants their test results and information regarding
how to interpret and understand their test results. This link filewill onlybe accessible
to the researchers and will not be kept past the project duration. In addition, a separate
filewillbe createdonlywith subjects' names, addresses, and phone numbers
exclusively for subjects who agree to be contacted for future studies. This filewillbe
kept beyond the project duration for recruitment of subjects for future related research.
8. Questionnaires, surveys, and testing instruments.
The Yale PhysicalActivitySurvey, the Postmenopausal Estrogens/Progestins
Intervention Physical Activity Questionnaire, the Block Food Frequency Questionnaire,
and the medical history questionnaire are attached.
9. Other approvals.
Attached is approval granted by the Rogue Valley Medical Center IRBon April 22,
1999.INFORMED CONSENT81
OSU Institutional Review Board (IRB)
OREGON STATE UNiVERSITY
Informed Consent Form
A. Title of the Research Project
Differences in Coronary Heart Disease Risk Factors between Active and Inactive
Women with Multiple Sclerosis.
B. Investigators
Jeff McCubbin, Ph.D. (principal investigator), Anthony Wilcox, Ph.D. (principal
investigator), Jennifer Slawta, M.S. (investigator), Rosemary Wander, Ph.D. (co-
investigator).
C. Purpose of the Research Project
Multiple Sclerosis (MS) affects twice as manywomen than men and coronary heart
disease (CHD) is responsible for the majority of deaths inwomen in the United States.
The United States Surgeon General designates physical inactivityas a major CHD risk
factor. Because physical activity substantially reduces CHD risk, in largepart, by its
association with favorable levels of blood cholesterol and low levels of abdominal fat,
the primary aim of the proposed study is to determine whether blood cholesterol levels
and abdominalfar differbetween active and inactive women with MS
We hope to determine whether more activewomen with MS are at a lower CHD risk
than less active women with MS. Furthermore,we hope that the information gathered
from this study will help establish minimal physical activity recommendations
necessary to reduce CHD risk in women with MS.
D. Procedures
Women with established cardiovascular disease, diabetes,or gout, women who
currently smoke more than 10 cigarettes per day orconsume more than 4 alcoholic
beverages per day, and women currently using thyroid, corticosteroid,or gout
medications, will not participate in the proposed study. Data collection for each subject
willrequire approximately 2.0 hours to obtain. During the labvisit:
1.) Bloodwillbe collected from a forearm vein for measurement of blood
cholesterol levels following a 12hour fast.
2.) Body weight and heightwillbe measured in light clothing without shoes.
Waist and hip circumferenceswillbe measured with atapemeasure for
estimation of abdominal fat. Skinlold thicknesseswillbe measured with a
skinfold caliper at 4 sites on the right side of the body (back of theupper
arm, below the shoulder blade, abdomen, and calf) for estimation of total
body fat. All body fat measurements and recording of body fat
measurements will be conducted by trained female technicians.
3.) Information regarding physical activity, eating habits, and medical history
willbe obtained by interviewer- and self-administered questionnaires.
Although the questionnaires may seem tedious, the information gathered82
from these questionnaires is necessary to estimate the extent by which
overall health behavior and medical history differencesmay contribute to
CHD risk in women with MS.
E. Risks and Discomforts
Some discomfort and minor bruising may occur during the blood draw. To minimize
discomfort and the risk of infection, sterile procedures during the blood collection will
be used by a trained technician, and finn pressure anda bandage will be applied to the
vempuncture site following the blood draw.
Minor discomfort may be associated with the skinfold measurements from the pinching
of the skin with the skinfold calipers. Discomfort will be minimized by having
experienced lab assistants conduct the skinfold measurements according to standardized
procedures to reduce the time necessary to achieve accurate measurements.
F. Benefits
Subjects participating in the studywillreceive information regarding their: 1.) lipid and
lipoprotein-cholesterol profile, and current recommendations from the National
Cholesterol Education Program and the Lipid Clinics' Follow-up Study to help them
interpret and understand their test results; 2.) dietary intake of total fat, saturated fat,
cholesterol, sodium, fiber, and antioxidants, and current recommendations from the
American Dietetics Association to help them understand their dietary assessment; 3.)
total and abdominal fat measurements, and comparisons to national normative values
and to values associated with increased health risks for women; and 4.) total
accumulated time spent in physically active behaviors duringa typical week, and
recommendations from the United States Surgeon General regarding how much
physical activity may be necessary to achieve health-related benefits.
G. Confidentiality
Subject information will only be available to the researcher and research staff of the
proposed study. Subjects identity will remainanonymous in the study results by the use
of identification numbers instead of names in the data entry and analysis.
Confidentialitywillbe respected regarding the data received in the proposed study.
H. Voluntary Participation
Your participation in the study is completely voluntary andyou may withdraw from the
studyat any time without prejudice.
L Questions regarding the study
Questions regarding your participation in the study, testing procedures,or any other
concerns will be answered by Anthony Wilcox, PhD. (principal investigator) (54 1-737-
2463), Jeffrey McCubbin, Ph.D. (principal investigator) (541-737-5921),or Jennifer
Slawta, M.S. (investigator) (541-535-8315). Questions regardingyour rights as a
research subject will be answered by Mary Nunn, Director of Sponsored Programs,
OSU Research Office: 541-737-0670.83
J. Understanding and Consent
Your signature below indicates thatyou have read and understand the foregoing and
agree to participate in this study. You will receivea copy of this consent form.
Signature of Subject Date Signed
Signature of Investigator Date Signed84
APPENDIX C
MODIFIED YALE PHYSICAL ACTIVITY SURVEY85
VIGOROUS ACTIVITY
Any activity similar to walking faster than 4.5 mph (fast walking, jogging, swimming laps or exercycling
somewhat strenuously)
1. Do you do any vigorous physical activity?
2.If yes, what is this vigorous activity?____________________
3. How many minutes/hours do you spend doing this activity in a week?_______
<10 minutes = 0
10-30minutes 1
31-60minutes=2
61-90minutes=3
91-120 minutes = 4
121-150 minutes = 5
151-180 minutes
>180 minutes = 7
4. How frequently is this activity performed?_________________
None =0
1-2 days/week = 1
3-4 days/week = 2
5-6 days/week =3
MODERATE ACTIVITY
Any activity similar to walking briskly (3-4 mph): brisk walking, water aerobics, easy to moderate
exercycle or swimming.
1. Do you do any moderate physical activity?
2.If yes, what is this moderate activity?______________
3. How many minutes/hours do you spend doing this moderate activity in a week?
4. How frequently is this activity performed?_________
LEISURE WALKING/LIGHT ACTIVITY
Any activity similar to walking leisurely (2 mph): leisurely walking, yoga, stretching.
1. Do you do any light activity or leisurely walking?
2.If yes, what is this light activity?______________
3. How many minutes/hours do you spend doing this light activity in a week?
4. How frequently is this activity performed?_____________APPENDIX D
BLOCK FOOD FREQUENCY QUESTIONNAIRE87
RESPONDENT ID
NUMBER ToDAY'S DATE
SJanDAYYEAR
QUESTIONNAIRE
;©i2000
2OO1
Gx2002
Aug 2003 -
Sep :2OO4:
:oct 2OO5
Nov®2OO6
ODec 2oO7©
This form is about the foods you usually eat. SEX AGE WEIGHTHEIGHT
It will take about 30-40 minutes to complete. ohale pOundS tt.in.
Please answer each question as best you can.
Female
Estimate If you aren't sure.
Use only a No.2 pencIl. If female, are you
Fill in the circles Completely, and erase breast feeding?
completely It you makecwgL
No
CYes
Please print your name in this box. Not
__________ L
FIrst, a few gsn.ial questions ' 1-2 34 54 1 liD 2 3 4.
about what you sat. ONCE par per per per per per par per
perWEEK WEEK WEEKDAY DAY DAY DAY DAY ________WEEK
About how many servings of vegetables 1
do you eat, per day or per week, not I
counting salad or potatoes?
About how many enangs of fruit do you oo0
eat, not counting juices?
How often do you eat cold cereal? 000000000
How often do you use tat or oil in cooking?000000000
What kinds oftator oIl do you usually use In cooking? MARK ONLY ONE OR TWO
0 Don't mow, cc Pam0 Butterftnargaflne blend0 Lard. talback. bacon tat
oStick margailne 0 Low-tat margarine 0 Cnsco
o softtub margarine 0 Corn*vegetable oil
OButter OOliveoilorcanolaoil
PLEASE DO NOT WRITE *4 ThA&A U00000soo00000coco 1849400
00
00I'
00
0
0S
00
00
00
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0 '0
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00
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00
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:11
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x
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flldI
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00
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()
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(1
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I
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U
±
1)
)
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()(100
0
fl
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p
b
iih
liii
ii i.
' ' 1' O Oi OUOO0.&
®
Ii.' i.i (Jn LI- 0101 01 01 01 01 01 0 I 66
1)" (p. (p. (J 0-0- 0" 0" 0- 0- 0'.ig e6
0-0- 0-0- 0- 0-0- 0- 0- 0- 0- 0-
I
00
d d d thjko dtdnui
II
000 1) 1) 00100000 00
000 0 O 0000000
O00 0O 0000000
000 0 O 0 0000000
___
00 0 0
O C)0 00 jo0 0 0 0 0 0 00
00OOO00000000 0 0
00 (1 000 0
0(JOU °1 0 000000
4' 00
o a a
G 4'
b ill I II
:1 jOO 1
z .
ii!juiji1I ii
H hi IPI.EASE 00 NOT WPVTE IN This AREA
18494 ccCCcCCcoUcccCcCcuuuU*
AFEWI 2-3 2
ONCE UMES ONCE 'llMES!BMES;UMES
HOW MUCH EACH TIME
HOW OFTEN NEVER'SI SEE PORTION SIZE
YEAR MONTh MONTh WEEK 'WEEK WEEK WEEK DAY PICTURES FOR A-B-C.D
How often do you eat each of the following fruits, just during the 2-3 months when they are in season?
Raw peaches. apricots. nectarines. _. [Howmany--- -
while they are in season " C) -- each timej
Caritaloupe,inseason C)'C!CC.CCCfHowmuch C
11$ 1/4 1 I
Strawbernes,inseason oC):C'C:c,C -Howmuct,
Watermelon,inseasonC,oCczHowmuth
Any other fruit in season, like -- - --- -
grapes, honeydew, pineapple, kiwi_C.____ Howmuch
How often do you eat the following foods all year round? Estimate your averagefor the whole year.
Bananas C CCC C C CC
Applesorpears CC)CC CCC : :
Orangesortangerines C.CC;CC CC CC _
Grapefruit CC Howmuch:CCC
i lIZ1,2 3
Canned fruit like applesauce, fruit
cocktail. ordriedfruitlikeraisins 0 C C , -. Hmuch 0W _-
eggs, incluoing egg biscuits or gg HOW many
'j McMutfins (Not egg substitutes) - - - iggs each time 7
j
Bacon CC)00CC CCi0
Howmany-.-')
Breakfastsausage,including C CCCC CCH1flYojo
D
Pancakes, waffles, French toast,0©CC © CC
Breakfast bars, granola bars. CCcC0 00 0 CHow many0 00
C C C00 C).C)C).Whichbow
C 010COICICIC)DWhiChbowlCIOC
Which high-fiber cereal do you eatmost often? MARK ONLY ONE: Au Bran or Bran Buds C Raisin Bran
C Fiber One, Fruit-n-Fiber. etc. 0 Something else C I don't know C I don't eat it
Just Right or
. C C CWhich bowlC 00
Anyothercoldcereal,hkeCom C©CCCC C CCWhichbowl0 0
Milk or milk substitutes on cereal CCCCC C C C C
How manyC) 0 CC
oz. on cereal3z I45ø. 6.70z.s..
Yogurt orfrozen yogurt CCCCC C C C CHowmuchC) ()
010CCCjC)C C0
Ho%many
When you eat cheese, is it C Usually low-fat C Sometimes low-fat C Hardly ever low-fat C Don't know/don't eat
PAGE 4I
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APPENDIX E
MEDICAL HISTORY QUESTIONNAIREMedical History Questionnaire
Personal History
Are you currently employed? __________(no)____________(yes)
How many years since your diagnosis with MS?
Personal Habits
Do you currently smoke? _______(no) (yes)
If yes, how many cigarettes doyou smoke each day?
If no, have you ever smoked cigarettes inthe past? _________(no) (yes)
If yes, indicate when didyou quit smoking________
Do you currently drink alcohol? (no) (yes)
If yes, how many alcoholic drinks doyou drink per
day? week? month?_________
Personal Medical History
Have you gone throughmenopause (no) (yes)
Ifyes, at what age?_______________________________
Medications
Current medication useNoYes (name/dose)
Insulin or other
diabetic medications
Thyroid medications
Gout or uric acid-
lowering medications
Corticosteroids
Blood pressure
medications
Cholesterol-lowering
medications
Hormone replacement
therapyMobility
97
Check one of the following boxes which
best describes your level of mobility X
I have no restriction on activities of
normal employment or domestic life, but
I am not necessarily symptom-free.
I am able to walk on level surfaces using
no aids for short distances only (for about
15 minutes) before I must stop andrest.
I am able to walk alone but mustuse
aids (walls, furniture, cane crutches,
walker, or braces).
I can walk a few steps but usuallyuse a
wheelchair.
I use a wheelchair and cannot walk, but I
have the ability to transfer.
I use a wheelchair exclusively, and I
cannot transfer.
I must be in bed all or most of the time.
9798
APPENDIX F
POSTMENOPAUSESTROGENS/PROGESTINS INTERVENTION
PHYSICAL ACTIVITY QUESTIONNAIREThe Posimenopausal Estrogens/Progestins Intervention Physical Activity Questionnaire
For a through c below, use the following as a guide to describe your activity level:
1.Physical Inactivity: The inactive person spends most waking hours sitting or
standing quietly. Activities include working at a desk, reading, watching television,
or other quiet pursuits. Usually does not walk more than a few minutes.
2. Light Physical Activity: This person usually walks more than 10 minutes ata time
each day, leisurely rides a bicycle, fishes, bowls, golfs, or engages in light
carpentry, light gardening, light industrial work, teaching, orlighthouse work on a
regular basis.
3. Moderate Physical Activity: This person participates in such activitiesas brisk
walking, recreational or doubles tennis, or swimming; or works in such occupations
as mail carrier, telephone repair,lightbuilding, and construction; or engages in
housework and home repairs or moderate gardening.
4. Heavy Physical Activity: This person performs vigorous activityon a regular basis,
including jogging, singles tennis, paddleball, or high-intensity aerobics; or engages
in heavy activities, such as carrying heavy weights (20 lb. or more), strenuous farm
work, or strenuous gardening.
a.Thinking about the things you usually did at work during the last 12 months, how
would you describe the kind of physical activity you performed?
Inactve______Light____Moderate ____Heavy ____Not applicable
b.Thinking about the things you usually didin your homeduring the last 12 months,
how would you describe the kind of physical activity you performed?
Inactive_____Light_____Moderate_____Heavy
c.Thinking about the things you usually didin your leisure timeduring the last 12
months, how would you describe the kind of physical activity you performed?
Inactive_____Light_____Moderate_____Heavy100
APPENDIX G
LITERATURE REVIEW101
Introduction
CHD contributes to the majority of deathsamong men and women in the United
States (36). Physical inactivity is designatedas a major risk factor for CR1)
(36,82,109,123). Physically inactive individualsare 1.5 to 2.4 times more likely to
develop CHD relative to physically active individuals (82). Womenwith MS are
frequently less active than sedentary women without MS (76,87),yet some women with
MS remain physically active despite their disability. However, it isunknown whether
women with MS are able to participate in enough activity to achieve health-related
benefits and to reduce their CR1)risk.
Although CHD is equally prevalent inmen and women, the relative contribution
of risk factors for CHD differ betweenmen and women. For instance, high circulating
levels of TO and low circulating levels of }]DL-Care more important predictors of CRD
risk in women when compared with men (72). Furthermore,among women, high TG
levels and low HDL-C levels are stronger predictors for CHI) thanhigh levels of total
cholesterol LDL-C (72).
Abdominal fat gain and insulin resistanceare believed to precede and be largely
responsible for CR1) risk-related increases in circulating levels of TO andCHD risk-
related reductions in HDL-C (2 1,24,57). In this regard, high lipolyticactivity of
abdominal fat cells increases free fatty acid (FFA) flux to the liver, which inturn, impairs
hepatic insulin extraction, thus contributing to hyperinsulinemia andinsulin resistance
(4 1,96,98). Insulin resistant-related alterations in the activities of thelipoprotein
enzymes are ultimately responsible for higher circulating levels of TG and lower
circulating levels of HDL-C (7,24,41,98). Therefore, obesity, in particular,abdominal
obesity is a major risk factor for insulin resistance and CHD.
The first section of the literature review will introduce M and addressthe
etiology, epidemiology, and medical treatments associated withMS. Because insulin
resistance is believed to precede and be largely responsible for CHD-relatedmetabolic
disorders including high circulating levels of TO and low circulatinglevels of HDL-C
(21,24,53), the second section of the literature review will address insulinresistance and
its biological association with high TG levels and low HDL-C levels.102
Physical activity reduces the risk for CR1), in part, by loweringtotal and
abdominal fat, improving insulin resistance, loweringplasma TG levels, and raising
plasma HDL-C levels (21,82,100,123,124). Thus, the thirdsection of the literature
review will address the influence ofphysical activityon the insulin-resistant CHD
metabolic profile. Because reductions in physical activityfrequently accompany aging,
consistent participation in physical activitymay, perhaps, prevent some of the age-related
increases in obesity and its associated metabolic and hormonaldisorders.
The symptoms of MS can interfere with and limit lifeactivities in persons with
MS. Furthermore, several perceived barriers prohibitparticipation in physical activity by
persons with MS including fatigue, mobility transportation, fear, and ovetheating
(113,114,115). However, current physical activity guidelinesendorsed by the United
States Surgeon General (123) and the American Heart Association(109), which
recommend a broad range of frequent bouts of moderate-intensityphysical activity
accumulating 30 minutes each daymay be attainable by persons with MS. Thus, the
fourth sectionofthe literature review will address physical activity inpersons with MS,
and the role that nonvigorous, moderate-intensity physicalactivity can have on
improving physical functioning and reducing CHD risk inpersons with MS.103
The Etiology and Epidemiology of MultipleSclerosis
There are currently between 250,000 and400,000 physician-diagnosedcases of
MS in the United States (3,103), and 8000new cases are diagnosed each year (87).
Because MS is difficult to diagnose, and becausethere are no concrete diagnostic tests
for MS, the incidence of MS is likelyto be greater than 400,000 (87). In fact,autopsy
studies suggest the incidence of MSto be two times higher than prevalence estimationsof
MS based on physician diagnosis (103).
There is a gender, genetic, and geographicalpredisposition towards MS. In this
regard, women are twice as likely to developMS relative to men (87,89,102,103,114),a
child born to a parent with MS isat a slightly greater risk (2-4%) for developing MS
during his/her life, and theoccurrence of MS is more prevalent in geographical regions
located farther away from the equator (87,102,103).Furthermore, 95% of persons with
MS are Caucasian (102,103,114) and there isaslightlygreater tendency for MS among
the higher socioeconomic classes (103).
MS may be diagnosedas exacerbating/remitting, chronic progressive,or a
combination of exacerbating/remitting andchronic progressive (87,89). Prevention of
MS is unknown and clinical management ofMS is difficult (103,114). Early MS
frequently begins as exacerbating/remitting andovertime may develop into chronic
progressive (87,103). The clinicalcourse of the disease with regard to the severity of
symptoms, exacerbations, and progressions is highly variablefrom patient to patient
(87,103,114). Although a small percent ofpersons with MS may experience a very rapid,
progressive deterioration (87,114), the majorityof persons with MS will live 90% ofa
full life span and the majority of thesepersonswillremain ambulatory (87,103,114).
MS is an autoimmune disorder by whichthe body's immune system mistakenly
attacks and destroys the myelin sheaths surroundingand insulating axons ofneurons in
the CNS (87,102,103). Myelm is primarilycomposed of lipid and is responsible for
promoting smooth muscle conduction of electricalimpulses in the CNS (103). The
essential fatty acids, linoleic acid and linolenicacid, predominate in the lipid fraction of
myelin and are important nutrientsnecessary for brain growth and maintenance
(18,74,121). Communication betweenneurons in the CNS occurs in the form of action104
potentials. Action potentialsare generated at the nodes of Ranvier whichinterrupt the
layering of myelin at periodic intervalsalong the length of theaxon (11,70). Because
action potentials do notoccur in myelmated areas, the nodes ofRanvier permit the action
potential tojulnp from nodeto node as it propagates alonga myelinated fiber (11,70).
This type of conduction is termed'saltatory' conduction, meaningconduction that leaps.
In early MS, the blood brainbarrier is damaged by activatedT cells which mount
a cell-mediated immune attackon myelin and the myelin producing cells,
oligodendrocytes (87,103). Plaquereplaces myelin and contributesto the symptoms of
MS (75). The specific antigenunder attack is believed to beimmunodominant myelin
basic protein and/or target siteson the surface of the oligodendrocytes (87).Because the
immune system-mediateddemyelination begins at the nodes ofRanvier, the conduction
of current is impaired leadingto a reduced conduction rate and, inmore severe cases, a
complete block of conduction(87,103). Areas of demyelinationin the CNS are depicted
by white spots with magneticresonance imaging (103). Inflammation resultsfrom the
immune system's attackon myelin, which in turn,causes edema and interference with
nerve conduction in non-demyelinatingneurons lying in close proximity to theareas of
demyelination (103). Remyelinationallows for some replacement ofmyelin and
activation of oligodendrocytes damagedduring the demyelinationprocess (87).
However, the replaced myelin is thinwith more nodes of Ranvier relativeto the original
myelin (87).
Symptoms associated with MS,including fatigue, ataxia, spasticity,muscle
weakness, diTziness, numbness,clumsiness, slurred speech, blurredvision, and lack of
bladder control, are most oftenexperienced between theages of 20 and 40
(87,89,103,114), but are knownto occur in children and the elderly(87). Lower
extremity movement ismore frequently disturbed by MS thanupper extremity movement
(89). The symptoms of MSprofoundly interfere with and limitlife activities inpersons
with MS. In fact, MS restrictslife activities toa greater extent than any other chronic
disabling condition (89).
Although MS is known to beprimarily an autoinimune disorder,viral infections
(103) and nutritional factors(18,74,12 1) are hypothesizedto contribute to the
development of MS. For instance,viral infections arebelievedto contribute to the onset105
of MS by triggering the immune system's attackagainst susceptible myelin (103).
Furthermore, exacerbations of the disease frequently followa viral infection (87,103).
Because essential fatty acids are critical for brain growthand development, and because
essential fatty acids are principle components of myelin(18,74,121), reductions in dietary
intake of essential fatty acids or altered essential fatty acidabsorption and metabolism
during a critical period in early brain developmentmay increase the susceptibility of the
CNS to demyelination in later life (18).
The incidence of MS is geographically greater inpopulations consuming diets
high in saturated fat and diets low in essential fats(1,18). In contrast, populations with
richintakes of essential fatty acids have lowrates of MS. In fact, MS is nonexistant in
Eskimos (103), a population known toconsume high dietary amounts of essential fatty
acids from the predominance of fish in their diets.Furthermore, reductions in the
seventy and frequency of exacerbations, and reductionsinoverall deterioration, are
observed when saturated fat is replaced with polyunsaturatedfat (117). Levels of
essential fatty acidsinthe blood of persons with MSare frequently low, and reduced
levels of unsaturated fatty acids and elevated levelsof saturated fatty acids are frequently
observed in the white matter of brains dissected frompersons with MS (121). Levels of
linoleic acid contained in circulating lipoproteinsare frequently reduced in persons with
MS (74,121) and replaced with saturated fat, primarilypalmitic acid (74). Furthermore,
levels of linoleic acid in circulating lipoproteinsare progressively reduced with
deterioration of the disease (74,121). One explanation for thelower levels of circulating
essential fatty acids in persons with MSmay be that a large proportion of essential fatty
acids are used for the synthesis of prostag,landins (74)involved in the inflammatory
response associated with MS. Linoleic supplementationmay reduce the severity and
duration of exacerbations, and the progression of disabilityin MS patients with mild or
no disability (33). The mechanism by which linoleic acid supplementsmay reduce the
progression of MS is not known. However, it is hypothesizedthat linoleic-derived
prostaglandins suppress the immune system's attackon myelin (33).
Several medications are available to ameliorate thesymptoms associated with MS
and to improve the functioning ofpersons with MS. Corticosteroids reduce inflammation
in the CNS associated with exacerbations (87,103).Evidence suggests that the majority106
of women with MS (>60%) have undergoneat least two courses of corticosteroid
treatment (114). A high dose of corticosteroids fora short period of time is
recommended to reduce the duration and severityof exacerbations. However, extended
period of corticosteroiduse may increase the risk for osteoporosis, diabetes, andCII{D
(87).
Betaseron (Interferon B), a synthetic proteinstructurally similar to myelin basic
protein, is effective in reducing the severityand duration of exacerbations primarilyin
persons with exacerbating/remitting MS, butmay also be effective in some persons with
chronic progressive MS (87,103). A numberof medications are currently availableto
reduce spasticity in persons with MS includingbaclofen, diazepam (valium), clonazapam
(kionopin), dantrolene (dantrium), backspasm medications, and carbamazepine (tegretol)
(103). Hytrin and dibenzylineare alpha-blockers that are frequently prescribed for
bladder control (103).107
Insulin Resistance and itsContribution to High Plasma Levelsof TG
and Low Plasma Levels of HDL-C
Insulin is an important hormone inthe regulation of blood glucoselevels. Insulin
is secreted from the beta cells inthe pancreas inresponse to high circulating blood
glucose concentrations followinga meal, and is responsible for mediatingglucose
disposal into target tissues of thebody. Abnormally high bloodglucose concentrations
are suggestive of a disturbance in insulinsensitivity, characterized byan impairment in
glucose disposal into target tissues,and/or a disturbance in insulinresponse,
characterized by an impairment ininsulin secretion from the beta cells.
Insulin-dependent diabetes mellitus(IDDM), or type I diabetes is manifestedby
an impairment in beta cell secretion of insulinand accounts for 10% of the American
population diagnosed with diabetes(100). By contrast,insulinresistance is characterized
by a deterioration ininsulinsensitivity in peripheral tissues andan increase in hepatic
glucose output, which in turn, leadsto higher plasma glucose levels (hyperglycemia),an
increase ininsulinsecretion from thepancreas to compensate for the hyperglycemia,and
ultimately the development ofnomnsulin-dependent diabetes mellitus (NIDDM),or type
2 diabetes (96,9 8). NIDDMaccounts for 90% of the American populationdiagnosed
with diabetes (100). Furthermore,insulin resistance is believedto precede and be largely
responsible for CHD-related metabolicdisorders including high plasma TGlevels and
low HDL-C levels (21,24,57).Thus, insulin resistance is believedto be the initial
metabolic disorder in the developmentof N[DDM and C}{D (21,24,26).
Evidence from the Frammgham studysuggest that theriskfor cardiovascular
disease is three times higherindiabetic women and two times higherin diabetic men
relative to their nondiabeticcounterparts (55). Althougha large portion of the increased
CHDriskamong diabetics may be attributed to thepresence of established CHDrisk
factors, including high TG levelsand low HDL-C levels,a significant portion of the
increased CHDriskamong diabetic patients is not entirely explainedby increases in
Clii)riskfactors (41). In fact, insulinresistance and compensatory hyperinsulmemia
increase theriskfor ischemic heart disease (23)and CHD-related events (i.e.,non-fatal108
myocardial infarction or CHE) death) (94) independently from their relationshipwith
other known biological CHD risk factors.
High blood glucose levels, representative of 'full-blown' NIDDM, ultimately
result from the combination of a deterioration in insulin sensitivity anda reduction in
glucose-mediated insulin secretion from the pancreatic beta cell (9,96,98). In the early
stages of insulin resistance, the beta cell may secrete large amounts of insulinto
compensate for a deterioration in insulin sensitivity in an attempt to maintain nonnal
blood glucose levels (9,96,98,124). Thus, the onset of insulin resistancemay initially be
characterized by elevated circulating insulin levels (compensatory hyperinsulinemia).In
fact, insulin resistant individuals frequently have normal levels of fasting glucosedue to
the ability of the pancreas to secrete large amounts of insulinnecessary to overcome the
resistance of the body's tissues to insulin (96,9 8). Thepancreaswillcontinue to secrete
more and more insulin in response to a progressive deterioration in insulin sensitivity and
greater blood glucose levels. Therefore, the degree of insulin resistancemay be best
determined by measuring circulating concentrations of insulin. In the latter stages of
insulin resistance, however, insulin stores may become depleted, such that thepancreas
may cease to secrete enough insulin to maintain normal blood glucose levels (9,96,124),
which in turn, leads to high circulating blood glucose levels.
Biological disorders related to insulin resistance can manifest at 4 major sites in
the body, including adipose tissue, hepatic tissue, skeletal muscle tissue, and pancreatic
tissue. Primary enzymes that may be adversely influenced with insulin resistance and
that may contribute to insulin resistant-related disorders in adipose tissue, hepatic tissue,
skeletal muscle tissue, and pancreatic tissue include hormone sensitive lipase (HSL),
lipoprotein lipase (LPL), lecithin cholesterol acyltransferase (LCAT), hepatic lipase
(HL), and cholesterol ester transfer protein (CETP). A brief review describing how HSL,
LPL, LCAT, HL, and CETP normally functionswillfollow so that the adverse effects
that insulin resistance may have on the primary enzymes,andultimately on circulating
TG andHDL-C levels, may be more easily understood throughout the text.109
Hormone Sensitive Lipase
HSL is located in adipocytes (fat cells) and skeletal muscle cells, and is
responsible for catalyzing lipolysis (breakdown) of stored fat (in the form of TG) into
glycerol and three FFA which are the basic structural components of the TG molecule.
FFA released by HSL-induced lipolysis of TG have a number of different fates. For
instance, FFA may be oxidized for energy by the cells in which theywere generated
(11,43), FFA may be releasedintothe bloodstream to circulate to other tissues of the
body (11,43), and FFA may recombine with alpha glycerolphosphate (a substrate formed
during glucose metabolism) to reform TG in adipocytes and skeletal muscle cells (11,43).
FFA released into the bloodstream from abdominal adipocytes travel directly to the liver
and increase the liver's production of TG-rich very low-density lipoproteins (VLDL), the
main transport vehicle for TG during fasting conditions. By contrast, glycerol's only fate
is to be releasedintothe bloodstream. Thus, the presence of glycerol in the bloodstream
is frequently used to determine the rate of lipolytic activity (11,43). Furthermore, it is
important to understand that glycerol must first be phosphorylated to alpha
glycerolphosphate by glycerol kinase in the liver before it can recombine with FFA to
form TG in adipocytes and skeletal muscle cells (11,43).
The primary hormonal mediators of HSL include the catecholamines,
norepinephrine and epinephrine (11). Binding of norepinephrine and epinephrine to beta
adrenergic receptors on adipocytes and skeletal muscle cells stimulate HSL and lipolysis,
whereas binding of norepinephrine and epinephrine to alpha adrenergic receptoTson
adipocytes and skeletal muscle cells inhibit HSL and lipolysis (11,43). Thyroid
hormones and androgens (male sex hormones) increase lipolysis by increasing the
number of beta adrenergic receptors (11). Thus, the increase in beta adrenergic receptors
by androgen and thyroid hormonal activity further increases the potential for
catecholamines to bind to the beta adrenergic receptors and stimulate lipolysis. Growth
hormone increases lipolysis by stimulating the synthesis of HSL (11). By contrast,
insulin inhibits lipolysis by decreasing the number of beta adrenergic receptors and by
stimulating phosphodiesterase which inhibits the activity of HSL (43). Thus, insulin110
resistance results in a loss of insulin-mediated suppression of HSL and, therefore,
contributes to a greater rate of lipolysis and plasma FFA.
Lipoprotein Lipase
LPL is an enzyme bound to the endothelial capillary lining of the heart, skeletal
muscle, and adipose tissue, and is responsible for hydrolysis of the TGcore of
chylomicrons (i.e., the main transport vehicle for TG in the fed state) andvery low-
density lipoprotein (VLDL) particles (10,41). Each TG molecule is hydrolyzed by LPL
into glycerol and three fatty acids, which may be removed from the circulation by target
tissues and used for either energy production or energy storage (31,37,41). Chylomicron
and VLDL remnants are formed after repeated LPL-mediated hydrolysis of the TGcore
of chylomicrons and VLDL particles, and are removed from the circulation by the liver
by hepatic apoB/E receptor recognition of apolipoproteinE1lying on the surface of the
circulating chylomicron and VLDL remnants (31,37,41).
LPL is also involved in the formation of mature-HDL3 particles. HDL3 particles
are formed when phospholipids and apolipoproteins are transferred from TG-rich
chylomicrons and VLDL particles to nascent HDL3 particles during LPL-mediated
hydrolysis of the TG core of chylomicrons and VLDL particles (31,37,41,118). Thus,
increases in LPL activity ultimately lower circulating levels of TG and raise circulating
levels of HDL-C.
Insulin stimulates LPL to hydrolyze TG into glycerol and three fatty acids (7,43).
Furthermore, by increasing glucose uptakeintoadipocytes and skeletal muscle cells and
by increasing the availability and uptake of FFA by stimulating LPL, insulin promotes
the reformation, or reesterification, of stored TG within adipocytes and skeletal muscle
cells (11,43). Because insulin stimulates LPL, LPL may become increasingly less active
as insulin resistance worsens. The insulin resistant-related reduction in LPL activity
contributes to higher circulating levels of TG-rich chylomicrons and VLDL particles
(7,4 1), and lower circulating levels of HDL-C (41). Furthermore, chylomicron remnants
1Apoliproteins lie on the surface of lipoprotein molecules and serve as recognition sites for cell receptors
on target tissues and as enzyme activators and enzyme inhibitors (9,35,104).111
being removed by the liver may contain greater amounts of TG whichmay further
promote VLDL production.
Lecithin Cholesterol Acvltransferase
LCAT is an enzyme responsible for the formation of HDL2 from HDL3
(31,41,118). Although HDL3 and HDL2 work together to remove cholesterol from the
artery walls, high levels of HDL2-C are most consistently associated with lower CH[) risk
(31,118). LCAT lies on the surface of HDL3 and promotes the esterification of
cholesterol with a fatty acid transferred from lecithin following HDL3-mediated removal
of nonesterified cholesterol from peripheral tissues. LCAT is responsible for the
translocation of esterified cholesterol to the core of HDL3. The accumulation of
esterified cholesterol within the HDL3 core by repeated LCAT activity shifts the dense
HDL3 particle to the less dense, antiatherogemc HDL2 particle (31,41,118).
Although the influence that insulin resistance may have on cholesterol efflux or
LCAT activity is not known, it is possible that an insulin resistance-related defect in
LCAT activity may contribute to reductions in circulating H1)L2-C. Some evidence
suggests that apolipoprotem A-i catabolism increases as insulin resistance worsens
(41,98). Because apolipoprotein A-I activates LCAT, an insulin resistant-related
increase in apolipoprotein A-i catabolism would reduce LCAT activity and subsequent
HDL2-C formation.
Hepatic Lipase
HL is an enzyme bound to the endothelial lining of hepatic tissue and is
responsible for either complete degradation of}{DL2into bile acids, or partial removal of
cholesterol from HDL2 and reformation of HDL3, which is then released back into the
circulation (31,118,122). Apolipoprotein A-i islostwhen HDL3 is reformed from HDL2
by HL (31,118), which may reduce LCAT activity and HDL2 formation. Thus, an
increase in Hi. activity may contribute to lower circulating levels of HDL-C. Some112
evidence suggests that greater HL activity is associated with lower HDL2-C in NIDDM
(41).
Androgens and estrogens (female sex hormones) have opposing influenceson HL
activity and RDL synthesis (122). Androgens are associated with increases in HL
activity and lower levels of circulating HDL2-C, and estrogensare associated with
reduced HL activity and higher levels of circulating HDL2-C (1122). However, older
men with reduced androgenic activity have low HDL-C levels (7). Therefore, the
associations between androgenic activity and HDL-C levels are not always consistent. It
is possible that age-related increases in abdominal fat which frequentlyaccompany age-
related reductions in androgenic activity in men (7)may contribute to lower circulating
levels of HDL-C in older men. In this regard, lower HDL-C levelsare associated with
greater amounts of visceral (intra-abdominal) fat in men of varying age (17).
Furthermore, increases in visceral fat are associated with increases in HL activity in
premenopausal women (21,22,24), such that premenopausal women withmore visceral
fat have greater HL activity and lower HDL2-C levels relative to premenopausalwomen
with less visceral fat, but similar amounts of total fat (22). Possible mechanisms
explaining the relationship between increases in visceral fat and increasesinHL activity
and lower Hl)L-C levelswillbe revisited later in the text.
Although the mechanisms underlying the regulation of sex hormones by HL
activity and HDL-C synthesis are not well-understood, possible regulatory sites by which
sex hormones may influence HL synthesis and HL activity include 1). Transcription of
IlL in hepatic tissue, 2). Post-translational modification of HL in hepatic tissue, 3).
Secretion of HL into the circulation, 4). Transport of HL from hepatic tissue to
endothelial tissue, and 5). Binding of HL to hepatic endothelial cells (122).
Cholesterol Ester Transfer Protein
CETP catalyzes the transfer of TG from chylomicron and VLDL remnants to
HDL2 particles and the transfer of esterified cholesterol from the core of BDL2 particles
to chylomicron and VLDL remnants (24,31,41,98,118). Insulin resistant-related
increases in circulating levels of TG stimulate CETP (31,41,96,98,118). CETP-mediated113
accumulation of TO within HDL2 particles may increase the susceptibility of HDL2to
hydrolysis by HL, thus lowering circulating levels of HDL-C (24,31,41,98,118,122).In
fact, the majority of evidence suggests that insulin resistant-related reductions in
circulating HDL-C levels are primarily mediated by increases in CETP activity
(24,41,98).
In summary, insulin resistant-related increases in the activities of HSL, CETP,
and HL, and reductions in the activity of LPL, ultimately contributeto high circulating
levels of TO and low circulating levels of HDL-C. The loss of insulin's inhibitory
influence on HSL with insulin resistance leads to increases in HSL activity, which in
turn, increases lipolysis, hepatic FFA flux, and VLDL production. An insulin-related
reduction in LPL activity reduces chylomicron and VLDL hydrolysis, which increases
circulating levels of chylomicrons and VLDL, and reduces circulating levels of HDL-C.
Again, chylomicrons are the main transporters for TG in the fed state and VLDLare the
main transporters for TO in the fasting state. Thus, an increase in circulating levels of
chylomicrons and VLDL is representative of an increase in circulating TO levels.
Furthermore, increases incirculatingTG levels stimulate CETP and the accumulation of
TG in HDL2, which in turn, increases the susceptibility of HDL2 to hydrolysis by HL,
thereby lowering circulating HDL-C levels. Therefore, high plasma TO levels and low
plasma HDL-C levels are believed to result from unfavorable alterations in enzymatic
activity which are mediated, in large part, by an increase in insulin resistance.
The cause of insulin resistance in humans is controversial. Abdominal fat is
strongly associated with insulin resistance and its associated CHD metabolic risk factors
(21,24,26,35,45,65,92), and may proceed the onset of the insulin resistant CuDrisk
factors (2 1,24). However, because studies examining the association between insulin
resistance and abdominal obesity frequently include human subjects whichare already
insulin resistant and obese, it is difficult to detennine the primarycause of insulin
resistance. The majority of evidence suggests that age-related increases in abdominal fat
largely account for the age-related increases in insulin resistance (16,45,63,106). In this
regard, high dietary fat intake, caloric intake in excess of caloric output, age-related
changes in circulating sex hormones, and age-related reductions in physical activity
largely account for abdominal fat accumulation (21). Increases in lipolytic activity of114
abdominal fat cells contribute to high levels of plasma FFA, whichmay be the initial
metabolic disorder contributing to the manifestation of insulin resistantCHD risk factors
(21,24,45). Greater amounts of abdominal fat inmen and women are consistently
associated with insulin resistant CHD risk factors, including higher fastinginsulin
(35,106) and fasting glucose (65) levels, higher insulin (35,92,106)and glucose
(35,65,92,106) responses to an oral glucose load, higher steadystate plasma glucose
levels during a hypermsulinemic, euglycemic clamp (63) and duringa hyperglycemic
clamp (61), and higher circulating levels of TG (13,25) and lower circulatinglevels of
HDL-C (13,17,25).
Visceral fat gain is believed to be the primary determinant in abdominal fat-
related increases in insulin resistance. Visceral obesity is characterized by large
adipocytes which are more resistant to insulin action (35), possibly resulting froma low
insulin receptor density in visceral fat and/ora posireceptor defect (i.e., a defect in
insulin's ability to suppress HSL activity7). Because visceral adipocytesare more
resistant to insulin, insulin-mediated suppression of lipolysis in visceral adipocytes is
reduced, which markedly increases the rate of lipolysis and FFA flux to the liver (41,96).
The increase in hepatic FFA flux inhibits the liver from extracting insulin from the
circulation (4 1,96), thereby contributing to a deterioration in insulin sensitivity,an
mcrease in plasmainsulinlevels, and insulin resistance.
FFA-mediated reductions in hepatic insulin extraction and increases in hepatic fat
oxidation markedly increase plasma glucose levels by reducing hepatic glucose uptake
and increasing hepatic glucose production (96,124). Reductions in hepatic insulin
extraction may reduce hepatic glucose uptake and contribute to high concentrations of
plasma glucose by indirectly reducing GLUT 2-mediated transport of glucoseinto
hepatocytes (liver cells). Although the GLUT 2 transport protein in hepatocytes isnot
directly dependent on insulin for its essential role in transporting glucoseacross hepatic
cell membranes, GLUT 2 is highly dependent on the glucose concentration gradient
between plasma and hepatocytes, which is directly influenced by insulin. High plasma
glucose concentrations relative to hepatic intracellular glucose concentrationswillfavor
GLUT 2-mediatedtransportof glucose from the plasma into hepatocytes. By contrast,
high hepatic intracellular glucose concentrations relative to plasma glucose115
concentrations will favor GLUT 2-mediated transport of glucosefrom hepatocytes into
the plasma. Insulin stimulates glucokinase,a key enzyme in hepatocytes responsible for
the irreversible phosphorylation of glucose to glucose 6-phosphateduring glucose
metabolism. The formation of glucose 6-phosphate by glucokinasereduces intracellular
glucose concentrations and, therefore, favors GLUT 2-mediatedtransport of glucose into
hepatocytes from the plasma, which in turn, lowers concentrationsof plasma glucose.
Because a FFA-related impairment in hepatic insulin extractionreduces glucokinase
activity in hepatocytes, intracellular hepatic concentrationsof glucose remain high, which
favors GLUT 2-mediated transport of glucose into the plasmafrom hepatocytes and
higher concentrations of plasma glucose.
Under normal conditions,insulinacts to inhibit glucose 6-phosphatase, an enzyme
unique to hepatocytes (and kidney cells) and responsible forconverting glucose 6-
phosphate to glucose during the reactions of gluconeogenesis,a metabolic process which
synthesizes glucose from noncarbohydratesources such as lactate, amino acids, and
glycerol. (11,43). Reductions in hepatic insulin extraction secondaryto hepatic FFA flux
removes the inhibition on glucose 6-phosphatase and, therefore, contributes to increases
in gluconeogenesis, hepatic glucose production, and plasma glucoselevels (124).
An increase in hepatic fatty acid oxidation increases concentrations ofacetyl-CoA
(a metabolic end product of fatty acid oxidation), which reducesglucose uptake and
metabolism by the liver, and increases hepatic glucoseoutput and plasma glucose levels
(96,98). More specifically, high concentrations of acetyl CoA inhibitpyruvate
dehydrogenase activity, a key enzyme responsible for convertingpyruvate to acetyl CoA
during glucose metabolism. Reductions in pyruvate dehydrogenase inhibitglucose
uptake and metabolism. In addition, high concentrations of acetyl CoAstimulate the
activity of pyruvate carboxylase, a keyenzyme responsible for converting pyruvate to
oxaloacetate during gluconeogenesis. By inhibiting pyruvate dehydrogenaseand
stimulating pyruvate carboxylase, fatty acid oxidation-related increases inacetyl C0A are
linked to reductions in hepatic glucose uptake and increases in hepaticglucose output.
Thus, reductions in hepatic glucose uptake and increases in hepatic glucoseoutput
substantially contribute to higher plasma glucose levels.116
It is important to understand that under fasting conditions, noninsulin-dependent
tissues, such as the brain, constitute the major sites of glucose uptake (124). Therefore,
reductions in glucose uptake into insulin-dependent tissues contribute littleto high fasting
blood glucose levels. Rather, the primary defect contributingto high fasting blood
glucose levels is believed to result from insulin's inability to effectivelysuppress hepatic
glucose production (98,124). However, hepatic glucose production is frequently
overestimated in individuals with high fasting glucose levels due to the inaccurate,
widespread use of calculations to compensate foran expanded glucose pool and the
resulting absence of steady state conditions when using isotopic techniques (98). When
more specific tracer techniques are used, which are not confounded by a large glucose
pool, hepatic glucose production is approximately 30% higher than normal in individuals
with very high levels of fasting glucose. Thus, other factors must contributeto high
fasting glucose levels in addition to increases in hepatic glucose production (98). For
instance, it is possible that abnormally high circulating levels of FFAmay impair
noninsulin-dependent glucose uptake, which would contribute to higher blood glucose
levels during fasting.
insulin resistant-related increases in potentially atherogenic VLDL particlesare
mediated by a number of possible and additive mechanisms, including increases in FFA
bepatic uptake, reductions in LPL activity, and high blood glucose-mediated
glycosylation of chylomicron and VLDL remnants. For instance, excessively high
delivery of FFA to the liver, secondary to higher rates of lipolysis in abdominal
adipocytes and higher plasma FFA levels, become the major precursors for endogenous
VLDL-TG synthesis and secretion (2 1,24). Furthermore, because insulin isa potent
stimulator to LPL, insulin resistant-related reductions in LPL activity also contribute to
higher circulating levels of VLDL particles and chylomicrons (7,41). Chylomicron
remnants removed from the circulation by the liver may contain greater amounts of TG
which may further promote VLDL production. It is also possible that abnormally high
blood glucose levels accompanying severe insulin resistancemay increase the
susceptibility of chylomicron and VLDL remnants to glycosylation (i.e., nonenzymatie
attachment of glucose), which in turn, may impair hepatic removal of chylomicron and
VLDL remnants (41).117
Insulin resistance is characterized by a deterioration in insulin sensitivity in
skeletal muscle and a reduction in insulin-mediated glucose disposal into skeletal muscle
(96,98,124). Because the GLUT 4 transport protein in skeletal muscle is directly
dependent on insulin for its action, a reduction in skeletal muscle glucose uptake with
insulin resistance most likely results in an impairment in GLUT 4-mediatedtransport of
glucose into skeletal muscle cells (124). More specifically, the binding of insulinto its
receptor on the skeletal muscle cell membrane surface stimulates the insulin signalling
pathway and the ultimate translocation of the GLUT 4 transport protein from its
intracellular location to the skeletal muscle cell membrane (11,43). The transport and
attachment of GLUT 4 to the skeletal muscle membrane isnecessary for its essential role
in transporting circulating glucose into skeletal muscle (11,43). Because insulin
resistance (44) and NTDDM (124) are not associated with low GLUT 4 concentrations,
the primary defect responsible for an insulin resistant-related reduction in skeletal muscle
removal of glucose is believed to result from a defect in the insulin signalling pathway
and the transport of GLUT 4 to the skeletal muscle membrane (43,124).
The possible mechanisms responsible for insulin resistant-related
impairments in GLUT 4 translocation are controversial (44,99,124). One possible
explanation accounting for the defect in insulin signalling and GLUT 4 translocation with
insulin resistance may be the increase in plasma FFA concentrations and skeletal muscle
fatty acid oxidation secondary to increases in visceral adipocyte lipolysis and/or high
intake of dietary fat Some evidence suggests that fatty acid oxidation-related increases
in acetyl CoA and reductions in pyruvate dehydrogenase activity (i.e., described
previously with respect to hepatic cells) within muscle cells inhibit glucose metabolism
and glucose transport into skeletal muscle cells via the glucose-fatty acid cycle (95). The
theory behind the glucose-fatty acid cycle suggests that the availability of fatty acids
determines the rate of fatty acid metabolism in the skeletal muscle, and that increases
skeletal muscle fatty acid oxidation inhibits the uptake and oxidation of glucose by
skeletal muscle by interfering with the insulin signalling pathway (95). In this regard, it
is hypothesized that high TG content in skeletal muscle cells, in response to high fat
feeding, favors fatoxidation,which, in turn, inhibits glucose uptake and metabolism via
fatty acid oxidation-related increases in acetyl CoA. In fact, insulin resistance (44,79)118
and visceral fat (44) gain are evident in rats after only 4 weeks of high fat feeding.In
addition, high fat intake-induced insulin resistance and visceral fat gaincan worsen and
progress into severe visceral obesity, severe hyperinsulinemia, severe hyperglycemia, and
over time, NTDDM (44).
In summary, increases in circulating levels of FFA impair glucose uptake into
hepatic and peripheral tissues, increase hepatic glucose production, increase hepatic
production of TG-rich VLDL, increase hepatic degradation of HDL-C by HL,and inhibit
pancreatic secretion of insulin (98). Furthermore, chronically high circulating plasma
FFA concentrations inhibit LPL activity which reduces the formation of HDL and further
contributes to high plasma TG levels. Thus, abdomirnil fat-related increases in plasma
FFA concentrations are believed to be largely responsible for insulin resistance-related
impairments in glucose metabolism and atherogenic alterations in circulating TG and
HDL-C levels, which in turn, profoundly increase the risk for NIDDM and CHD.119
The Influence of Physical Activityon Insulin Resistance and Circulating Levels
of TG and HDL-C
Approximately 12% of all deaths in the United States eachyear are related to
physically inactive, sedentary lifestyles (82). It is estimatedthat 29.2% of American
adults participate in no leisure-time physical activity,and 43.1% of American adults do
not participate in enough leisure-time physical activityto obtain any meaningful health
benefits (93). Furthermore, men participateinphysical activity more frequently than
women (82,93), and participation in physical activity declines withage (65).
The risk for developing NIDDM and CR1) increases withage, obesity, and lack
of physical activity (82,100). Physical activity isknow to reduce the risk for N]DDM
and CR1) by improving insulin resistant CR1) risk factorsincluding TG and HDL-C
levels, blood pressure, body composition, insulin sensitivity,and glucose tolerance
(82,123,124). In fact, physically inactive individualsare 1.5 to 2.4 times more likely to
develop CHD relative to their active counterparts (82).
Physical activity favorably influences insulin/glucose homeostasisby improving
insulin sensitivity and insulin action, primarily in skeletalmuscle, which in turn, reduces
insulin secretion from the beta cell (i.e., insulin response) andcirculating insulin levels
(27,61,82,124). For instance, Kirwan et al. (61) observed significantlylower fasting
insulin levels, significantly less insulin secretionto an oral glucose load, and significantly
less insulin secretion during a hyperglycemic clamp withouta change in glucose disposal
rate following 9 months of exercise training in elderly adults. Thelower insulin response
without a change in glucose disposal rate suggestsan increase in insulin sensitivity in
skeletal muscle (i.e., improvedinsulinresistance) with exercise training. Therefore,a
similar amount of glucose was infused before and after training,but a lower insulin
response to the infused glucose was observed following training, thereby demonstrating
the effect that exercise can haveon reversing the age-related reductions in insulin
sensitivity and glucose tolerance.
An increase in the concentration of the GLUT 4transport protein is believed to be
primarily responsible for the increase in insulin sensitivityand improved insulin
resistance associated with physical activity (53,124).Contraction-mediated glucose120
uptake is also enhanced by increasesGLUT 4 concentration with exercise (11).GLUT 4
expression in rat skeletal muscle increasesrapidly following the onset of exercise(99).
However, the exercise-related increase inGLUT 4 concentration and insulinsensitivity is
transient and, if exercise is not repeated,returns to baseline within 40 hours followingan
acute exercise bout (50). Thus, regular, consistentparticipation is necessary to maintain
improvements in insulin sensitivity. Theincrease in GLUT 4 concentration and insulin
sensitivity within the hours followingan exercise bout is associated with a replenishment
of glycogen stores (99).
Although increases in insulin physical activitywith exercise is primaiily
attributed to increases in the concentrationof GLUT 4, other mechanisms including
reducedinsulinsecretion from the beta cell, increasedcapillary density, improved
insulin-receptor binding and insulin signalling,and GLUT 4 translocationare also likely
to contribute to increases in insulin sensitivityand improved glucose tolerance with
exercise training (53,124).
An improvement in insulin sensitivity withphysical activity contributes to
reductions in circulating levels of TG andelevations in circulating levels of HDL-C byits
involvement in reactions which stimulateLPL activity and inhibit HSL, CETP, and HL
activities. Based on the mechanismspreviously described in the previous sectionof the
literature review, insulin-mediated increasesin LPL activity would lower circulating
levels of TG and raise circulating levels ofHl)L-C; insulin-related reductions in CETP
and HL activities would reduce HDLdegradation, and therefore, contribute to higher
circulating levels of HDL-C; and insulin-mediatedsuppression of HSL would reduce the
FFA flux to the liver, thereby reducingVLDL production and circulating TG levels.
Manipulation of lipoproteins is the primarymeans for treating and preventing
CHD (36). The National CholesterolEducation Program (NCEP) (36) and theAmerican
Heart Association (AHA) (39,109) recommendaltering lipoprotein levels through diet
modification and physical activityas the first line of treatment for primary prevention of
CHD in persons who are not otherwiseconsidered to be at risk for CHD. Physical
activity is associated with lower circulatingTG levels and higher circulating HDL-C
levels, specifically levels of HDL2-C (31,36,82). Consistent with fmdings reportinga
transient increase in insulin sensitivityfollowing acute exercise, elevations in levels of121
HDL-C (4,19,56,104) and reductions inlevels of TO (19) are observed immediately
following or in the first few days that followan exercise bout. If exercise is not repeated,
a considerable amount of these favorable metabolicchanges are lost within 4 8-72 hours
post exercise (19). Therefore, timing of bloodmeasurements following the last exercise
session is an important consideration, anddiscrepancies in findings across studies with
respect to metabolic changes accompanying physicalactivity may, in part, result from
differences in the timing of blood samples.
Recent evidence suggests that nonvigorous,low to moderate intensity exercise
contributes to health-related benefits comparableto those that may be achieved with
higher intensity exercise when controllingfor caloric expenditure (29,51,69,82).
Although some evidence suggests that elevationsin plasma levels of HDL-Care
associated with increases in the level ofexercise intensity (112), it is possible that the
higher energy expenditure (i.e., volume ofexercise completed) associated with higher
exercise intensity, is responsible for theelevations in HDL-C levels, independent from
the intensity level. For instance, when controllingfor energy expenditure by having
lower-intensity exercisers walk fora longer period of time than high-intensity walkers,
Duncan et al. (29) observed that high-intensitywalkers and low-intensity walkers hada
comparable rise in HDL-C levels despitean increase in aerobic capacity among the high-
intensity exercisers. Therefore,a disassociation was observed between physical fitness
(aerobic capacity) and health-related benefits(HDL-C levels). Similarly, comparable
improvementsininsulin sensitivity are observed between vigorouslyactive and
moderately active men andwomen when energy expenditures are equivalent (51).
Findings from King et al. (60) furthersupportthe benefits that can be achieved
with low-intensity exercise in that significantincreases in HDL-C were observed in older
adults following two years of participation ineither a low-intensity or high-intensity
home based exercise program, withno significant differences in the magnitude of HDL-C
increase from baseline between the exerciseinterventions. Furthermore, over 50% of the
low-intensity exercisers achieved elevations inHDL-C levels greater than 5 mg/dL,
whereas only 3Oto 35% of the high-intensityexercisers achieved elevations in HDL-C
levels greater than 5 mgfdL.122
Recent evidence also suggests thataccumulation of short bouts of physical
activity can contribute to health-relatedbenefits comparable toa single bout of physical
activity of longer duration. For instance,low-intensity exercisers in the Kinget al. Study
(60) participated inmore frequent, shorter bouts of exercise, whilehigh-intensity
exercisers participated in less frequent,longer bouts of exercise, yet improvementsin
HDL-C levels were most evident in thelow-intensity exercisers. Ebisu et al. (34)suggest
that three bouts of exercise each daysignificantly increase HDL-C levels relativeto
baseline. By contrast,one or two bouts of exercise each day of equivalenttotal exercise
duration as that achieved with the threebouts of exercise per day didnot significantly
raise H1)L-C levels from baseline (34).Angelopoulos et al. (4) observed HDL-Clevels
to be significantly higher followingone, two, or three acute bouts of exercise relative
baseline HDL-C levels, yet three boutsof exercise resulted ina higher and clinically
significant rise in HDL-C levels frombaseline relative to I or 2 bouts of exerciseeach
day. Furthermore, when examining thehealth benefits obtained between subjects
incorporating intermittent bouts ofmoderate-intensity physical activity accumulatingat
least 30 minutes each dayintotheir daily schedules and subjects followinga more
structured exercise program, favorablechanges in weight (54), body fat (2,30,54),waist
circumference (54), bloodpressure (30), total cholesterol levels (2,3 0), and TG levels(2)
were observed following both interventions, withno appreciable differences in any of
these outcomes between the exerciseinterventions.
Evidence demonstrating the health-relatedbenefits achieved with
consistent and frequent participation innonvigorous, moderate-intensity physicalactivity
have provided the underlying rationale forthe current national guidelines for physical
activity endorsed by the U.S. SurgeonGeneral (123), the Centers for DiseaseControl and
Prevention (82), and the American HeartAssociation (109). The current physical activity
guidelines recommenda broad range of physical activity (i.e., gardening,housework,
etc...) and encourage adults to accumulateat least 30 minutes of moderate-intensity
activity each day whichcan be achieved by either one 30-minute continuousboutor by a
number of short bouts of activity spreadthroughout the day (82,123). Current guidelines
emphasize physical activity rather thanexercise and physical fitness, andare aimed
primarily at those persons whoare most inactive since the have the most to gain froma123
public health perspective (47,82). Bydecreasing the intensity and increasing the
frequency and diversity of activity, therecommendations are more palatable for and
attainable by the general public. In fact,250,000 deaths each year in the UnitedStates
may be eliminated if all Americans followed thecurrent physical activity guidelines (82).
It is undetenrnned whether the favorablechanges in insulin sensitivity, plasmaTG
levels, and plasma H1)L-C levels whichfrequently accompany physical activityare
independent from physical activity-inducedbody weight and body fat loss. Favorable
increases in insulin sensitivity (27,61) andplasma HDL-C levels (29,132,133,134), and
favorable reductions in plasma TG levels(132,133) with physical activityare frequently
associated with favorable body compositionalchanges including reductions in body
weight, body fat, and abdominal fat, butnot always (112,120,126). Again, age-related
increases in abdominal fatare believed to substantially contribute to the onset of insulin
resistant-CHDriskfactors (21,24). Because reductions inphysical activity frequently
accompany aging, consistent participation in physical activitymay, perhaps, prevent
some of the age-related increases in abdominal obesity and itsassociated hormonal and
metabolic disturbances.
Several cross-sectional studies have observedthat leaner, physically active
individuals have more favorable lipid andlipoprotein levels than their heavier, inactive
age-matched counterparts (32,48,128,131).An association between body composition
changes and favorable alterations in selected lipidand lipoprotein levels is frequently
observed following chronic exercise training(27,29,132,133,134). For example, Duncan
et al. (29) identified women with the greatest reductionin body fat to have the greatest
rise in HDL-C levels when combiningwomen from all intensity-intervention groups
following a 6-month training period.
The first Stanford Weight Control Project(133) was designed to address the
influence of weight loss on levels of HDL-C.Weight loss occurred in bothmen who
dieted (caloric-restricted diet) andmen who exercised compared with controls, but the
men who dieted were able to achieve more weight loss comparedwith the men who
exercised. Significant reductions in TG levels in thedieters and exerciserswere also
observed and were significantly associatedwith reductions in weight. Although themen
who dieted lost more weight than themen who exercised, both groups elevated their124
HDL-C and HDL2-C levels similarly following the one-year intervention. The rise in
HDL-C levels was significantly related to reductions in fat and weight loss in bothmen
who dieted and men who exercised. Therefore, elevations in HDL-C levels in the diet-
induced weight loss group supports the argument that weight loss, whether accomplished
by diet or exercise, is necessary to raise HDL-C levels. Furthermore, Williamset al.
(130) observed that the association between distancerun and elevations in HDL2-C was
no longer significant after adjusting for BMI, and Williams et al. (129) observed that
elevations in HDL2-C levels in subjects exercising in combination witha low-fat diet
were no longer significant after adjusting for BMI or losses in body weight. Still, the
observation that men who exercised lost less weight than themen who dieted in the first
Stanford Weight Control Project (133), yet hada similar rise in HDL-C levels, supports
the argument that some other component exists, independent of weight loss, that is
contributing to the elevations in HDL-C levels in the men who exercised.
Favorable changes in the activities of the lipoproteinenzymes are frequently
observed in the presence of weight loss (27,107,111). Significantly greater postheparin
LPL activity and significantly reduced HL activity are observed in leaner malerunners
when compared with sedentary controls (48). Significant reductions in HL activity and
increases in LPL activity following exercise-induced weight lossare observed in obese
premenopausal women (27) and older men and women (107). Moreover, LPL activity is
increased and hepatic lipase activity is reduced when weight loss is achieved by either
diet or exercise (111).
By contrast, a number of studies have demonstrated that favorable CHI)
risk-reducing elevations in HDL-C levels (112,120) and LPL activity (126), and CHD
risk-reducing reductions in TG levels (126) and CETP activity (107)may occur without a
concomitant loss in weight. Significantly higher levels of HDL-C are observed in
physically active men and postmenopausal women aged 50-89years and significantly
reduced levels of TG are observed in physically activemen aged 50-89 years compared
with their inactive counterparts after adjusting .for either BMIor the WHR (97).
Furthermore, significant rises in levels of HDL-C are observed inmen exercising at 75%
and 85% of their aerobic capacity relative to inactive controls (112), and inmen125
following 15 weeks of moderate-intensity training (83), withouta loss in either body
weight or body fat.
Evidence from the second Stanford Weight Control Project (134) and the Diet and
Exercise for Elevated Risk (DEER) study (110) suggest that elevations in levels ofHDL-
C with exercise cannot be exclusively mediated by weight loss. In contrastto the caloric
restricted-induced weight loss diet in the first Stanford Weight Control Project, the diet in
the second Stanford Weight Control Project restricted calories by restricting dietary fatin
an attempt to more effectively lower LDL-C levels in overweight men and
premenopausal women. Although men who dieted, but did not exercise, lost significant
amounts of body fat and weight with the fat-restricted diet relative to controls, theywere
unable to achieve the rise in HDL-C levels previously observed inmen who lost weight
by reducing caloric intake in the first Stanford Weight Control Project. Furthermore, the
restriction of dietary intake of fat offset the favorable rise in HDL-C levels observed with
a caloric-restricted, but not fat-restricted weight loss diet.
Men who dieted and exercised in the second Stanford Weight Control Project lost
significantly more weight and fat, and achieved significant elevations in HDL-C levels
and significant reductions in TG levels relative to men who dieted (fat-restricted), but did
not exercise, and controls. However, it is unclear whether the significant rise in HDL-C
observed in men who dieted and exercised was obtained by the exerciseor by the
additional weight loss that occurred in men who dieted and exercised.
Weight loss was similar between women who dieted and exercised andwomen
who dieted, but did not exercise, in the second Stanford Weight Control Project (134).
However, the fat-restricted diet lowered HDL-C levels in thewomen who dieted, but did
not exercise, compared with women who dieted and exercised, and women controls.
Moreover, despite the influence of weight loss and exercise,women who dieted and
exercised were unable to raise their HDL-C levels in thepresence of the low-fat diet.
Similarly, Beard et al. (6) observed reductions in levels of FIDL-C inmen and women,
despite weight loss, following exercise in combination witha very low-fat diet regime.
Thus, elevations in HDL-C levels cannot be completely mediated by weight loss.
One possible mechanism explaining the lower levels of HDL-C observed with
low fat diets may be that less cholesterol, phospholipid, and apolipoproteins from126
circulating chylomicrons are available to be transferred to HDL with low fat diets (77).
Beard et al. (6) argue that low levels of HDL-C associated with low fat dietsdo not have
the same prognostic implications as do low levels of HDL-C associated with the typical
American diet. Although the NCEP (36) and the AHA (109) consider low levels of
HDL-C to be associated with increased risk, the Tarahumara Indiansconsume very little
fat and have HDL-C levels below the minimum advised levels established by the NCEP,
yet the presence of CIII) is extremely rare in this population (71). Still,a fat-restricted
diet may not be appropriate for persons with initially low levels of HDL-C. Nevertheless,
the inclusion of an appropriate dietary analysis across studies isnecessary to consider
how potential dietary differences among study participantsmay confound the
interpretations regarding the influence of exercise and weight losson circulating levels of
lipoproteins.
Findings from the DEER study (110) support the hypothesis that exercisemay
raise levels of HDL-C, independent from weight loss, and furthersupport the hypothesis
that fat-restricted diets lower levels of plasma HDL-C. In this regard,no significant
elevations in levels of HDL-C were observed in eithermen or postmenopausal women
with low baseline HDL-C levels who dieted (fat-restricted), but did not exercise,or in
men and postmenopausal women with low baseline levels of HDL-C who dieted (fat-
restricted) and exercised, despite similar and significant weight loss in bothgroups.
However, HDL-C levels tended to be higher in men and postmenopausalwomen who
exercised, but did not diet, even though weight losswas not achieved in either group.
Thompson (120) suggests that discrepancies across studies with respectto the
influence that weight loss has on HDL-C levelsmay, in part, be attributed to plasma
volume changes that have not been considered following the intervention period. More
specifically, reductions in plasma volume thataccompany dietary-induced weight loss
may lead to an overestimation of HDL-C levels. By contrast, plasma volume expands
following a chronic exercise trainingprogram and may lead to an underestimation of
elevations in HDL-C levels. Thus, a comparison between the effects of exercise with and
without weight loss on plasma volume needs to be addressedto better understand how
plasma volume changes may confound possible interpretations regarding the influence
that exercise and weight loss have on circulating levels of HDL-C.127
Elevations in }IDL-C levels and reductions in TG levels following
exercise training, independent from weight loss,may result from local adaptations
occurring at the level of the skeletal muscle (59,67). Cross-sectionally,Nikkila et al. (78)
observed significantly higher levels of skeletal muscle LPL activity inmale and female
long distance runners relative to their less active counterparts having thesame body
weight. Furthermore, a significant increase inmean skeletal muscle LPL activity was
observed in 6 Swedish elite soldiers on heavy workdaysrelative to inactive controldays,
and was related to urinary epinephrine excretion (67). Becauseepinephrine stimulates
lipolysis, increases in circulating epinephrine levels with physical workmay indirectly
stimulate LPL to replace skeletal muscle TG stores lost with the exercise.Kiens and
LithelJ (59) observed mean skeletal muscle LPL activityto be 70% higher in trained legs
relative to untrained legs following a well-controlled 8-week one-leggedtraining
intervention. The rise in skeletal muscle LPL activity in the trained legswas related to
arteriovenous differences in HDL-C and Hl)L2-C, and inversely relatedto arteriovenous
differences in VLDL-TG. In addition, the exercise-induced increases inskeletal muscle
LPL activity were associated with exercise-induced increases in capillarydensity, which
in turn, may create more binding sites for LPL.
Although controversy still exists regarding whether favorable changes ininsulin
sensitivity, TG levels, and HDL-C levels with physical activityare independent from
physical activity-induced weight loss, increases in insulin sensitivity(50) and HDL-C
levels (4,19,56,104), and reductions in TG levels (19)are observed immediately
following, or in the first fewdaysthat follow an acute exercise bout, independent froma
change in body composition. If exercise is not repeated,a considerable amount of the
favorable changes in insulin sensitivity, HDL-C, and TGare lost with 48 to 72 hours
following the last exercise bout (19,56). Therefore, it is possiblethat favorable changes
in insulin resistant CHDriskfactors are achieved by repeated acute bouts of exercise,
whereas reductions in total and abdominal body fatmay be more related to chronic
exercise training. In turn, chronic exercise-related reductions in total andabdominal
body fat may have long-term additive effectson improving the insulin resistant C}{Drisk
factors achieved by repeated acute bouts of activity.128
In summary, physical activity reduces CH[) risk, in largepart, by reducing total
and abdominal fat, improving insulin sensitivity and insulinresistance, reducing
circulating levels of TO, and raising circulating levels of HDL-C.Improvements in the
insulin resistant CHD biological risk factorsare mediated primarily by CHD risk-
reducing alterations in metabolic enzymatic activity.Furthermore, nonvigorous,
moderate physical activity can reduce CHD risk comparableto reductions in CHD risk
achieved with higher intensity exercise. Thus,current physical activity
recommendations, which emphasize less intense forms of physicalactivity, are more
attainable by the general public, and may increase long-termadherence to physical
activity by the general public. Moreover, because physicalactivity recommendations
emphasize a broad range of frequent, moderate-intensity formsof physical activity, these
guidelines may be attainable by persons with MS.129
Physical Activity in Persons with Multiple Sclerosis
With the continual development of new medications for the treatment of MS,
women with MS are likely to live full life spans. However, because physical inactivity is
a major risk factor for the development of NIDDM and CHD (36,82,123), and because
persons with MS are frequently more sedentary than age- and gender-matched sedentary
controls (76,87,113,114), persons with MS may be ateven greater risk for NTDDM and
Clii) with increasing age relative to their non-MS counterparts. For instance, the direct
measurement of physical activity with a three dimensional accelerometer (76) and the
indirect measurement of physical activity with the Health Promoting Lifestyle ProfileII
survey (114) identifr persons with MS as being less active than age- and gender-matched
controls.
Furthermore, extended or frequent periods of corticosteroiduse by persons with
MS raises N1DDM and CHDriskby stimulating lipolysis and proteolysis (protein
breakdown). Again, lipolysis increases FFA flux to the liver which impairs hepatic
insulin extraction and ultimately contributes to insulin resistance, high circulatinglevels
of glucose, high circulating levels of TG, low circulating levels of HDL-C,and the
development of NTDDM and CHD (2 1,96,98). Muscle proteolysis makes amino acids
available to the liver for glucose synthesis through the reactions of gluconeogenesis(11).
The diffusion of glucose into the bloodstream from the liver increases circulating levels
of glucose which further raises theriskfor developing NTDDM and CHD. Thus, regular
participation in physical activity, which is known to improveinsulinresistant CHD
biological risk factors, may oppose the negative influence that corticosteroiduse has on
the insulin resistant CHD risk factors (89,114).
Although it is likely that persons with MS who adopt physically active lifestyles
willachieve health-related benefits similar to the general population, several perceived
barriers, including fatigue, mobility, transportation, fear, and overheating, limitthe extent
by which persons with MS can effectively and consistently incorporate healthpromotion
practices into their daily lives (113,114,115). In fact, just the diagnosis of MS,
independent from the clinical status and severity of MS, is suggestedto be responsible for
the low activity levels in persons with MS (76).130
Fatigue affects the majority of persons with MS. Three types of fatigueare
experienced by persons with MS (103): 1). Normal fatigue that occurswiththe activities
of daily living. A considerable amount of this 'normal' fatiguemay be attributed to
deconditioning and muscle disuse associated with low levels of physical activity, 2).
Fatigue associated with impaired functioning of the CNS which is characterized by gait
disturbances and limping during short periods of wailcing. In more severe cases,a
complete block of nervous system conduction may occur causing walking tocease, and
3). Fatigue associatedwithdisturbances in neurochemical processes which manifests as
extreme sleepiness.
A rise in body in body temperature accompanying physical activity is a major
concern among persons with MS (87,113). Body temperature elevations contribute to
fatigue and worsen the symptoms of MS (86,87). Because water exercisemay lessen
body temperature elevations that frequently accompany land exercise, water exercisemay
be the preferred mode of physical activity for those with MS. Water exercise is perceived
as less stressful by persons with MS relative to identical exercise performed on land (89).
Furthermore, personswithMS report that "swimming provides a sense of self-efficacy
that cannot be achieved with other activities because water providesa buoyancy that
makes weak muscles feel strong (113)." When exercise must be performedon land,
however, cool showers prior to exercise, light clothing, and the operation of fans during
exercise may minimize heat intolerance associated with land exercise (87).
Persons with MS have lower aerobic capacities (80,89,90) and less muscular
strength, power, and endurance relative to their sedentary, otherwise healthy,
counterparts without MS. Less muscle strength and lower aerobic capacities in persons
with MS may be attributed, in large part, to the effects of cardiovascular deconditioning
and skeletal muscle structural changes associated with their low levels of physical
activity (5 8,80,90). Ponichtera-Mulcare et al. (90) observed that aerobic capacities of
persons with mild to moderate MS did not differ between maximum cycling efforts
performed in the water and maximum cycling efforts performedon land. However,
aerobic capacities of person with MS were lower in both exercise environments relative
to sedentary controls without MS, yet perceived fatigue was similar between the two
groups, and fatigue in persons with MS was not related to the symptoms of MS.131
Furthermore, some persons with MS had blunted heart rates to increasing workloads(90).
By contrast, Ogliati et al. (80) observed the heart rates ofpersons with MS to be higher
than heart rates expected from standard oxygen consumptionranges. Thus, the indirect
method of estimating maximum aerobic capacity from submaximum heartrate and work
rate data may not be accurate for the population with MS.
Oxygen pulse (stroke volume x arteriovenous oxygen difference), the major
component of aerobic capacity, is reduced in persons with MS, andmay be explained by
a reduction in stroke volume and/or artenovenous oxygen difference (80). Stroke volume
is the amount of blood pumped out of the heart each beat and isan index of
cardiovascular functioning. Low stroke volume inpersons with MS may reflect an
autonomic nervous system abnormality, common in MS, causing reductions in stroke
volume and increases in heart rate (80). The arteriovenousoxygen difference is the
difference betweerL the oxygen content in arterial blood and theoxygen content in mixed
venous blood. The arteriovenous oxygen difference reflects the amount of oxygen
extracted by the tissues and is dependent upon sufficient oxidative enzymatic activity,
capillarization, and mitochondrial density and activity. Thus, the arteriovenousoxygen
difference is an index of muscle functioning. Low arteriovenousoxygen difference in
persons with MS reflects muscle disuse and is consistent with smaller fiber size, less slow
twitch fibers (necessary for aerobic exercise), and lower succinate dehydrogenase activity
(an oxidative enzyme in the KREBS cycle required for aerobicenergy metabolism) in
skeletal muscle observed in persons with MS relative to healthy controls (58). In
addition, ventilation (80,119), breathing frequency (80,119), and the ventilatory
equivalent (VWVO2) (80) are observed to be higher inpersons with MS. A higher
ventilatory equivalent reflects greater anaerobic metabolism and less aerobic metabolism
resulting from lower oxidative capacities of the muscle from disuse. More specifically,
the buffering of lactic acid generated from anaerobic metabolism increases nonmetabolic
carbon dioxide production which stimulates ventilation and raises the ventilatory
equivalent (11).
Although several studies have identified persons with MSas being less active and
less aerobically fit relative to age- and gender-matched controls without MS
(76,80,90,119), only a few studies (86,108) have examined the improvements in aerobic132
fitness and CHD risk factors following an exercise intervention. In this regard,increases
in aerobic capacity (86,108), work capacity (86,108), and muscular strength (86),and
reductions in circulating levels of TG (86) and skinfold thicknesses (86)are observed
following 4 months of moderate-intensity aerobic exercise inpersons with MS ranging
from low to moderate disability. Furthermore, these health-related gainswere observed
without an increase in the incidence of exacerbationsor symptoms related to MS
(86,108). Shapiro et al. (108) observed thatpersons with more progressive MS (EDSS>
3.5)were able to significantly raise their maximum aerobic capacities, but not to the same
extent as persons with milder MS (EDSS>3.5)following a home-based endurance
exercise program. By contrast, Petajan et al. (86) observed maximum aerobic capacityto
be equally raised in mild and more progressed forms of MS followingan endurance
training intervention in a controlled, laboratory setting. Moderate reductions in plasma
TG levels were reported by Petajan et al. (86), butno favorable elevations HDL-C were
observed by Petajan et al. (86) or Shapiro et al. (108) following 4 months of exercise
training. Thus, it is possible that persons with MSmay require a longer training period to
raise plasma HDL-C levels. Moreover, no studies have measured changes in fasting
insulin levels or changes in insulin responses to an oral glucose load inpersons with MS
following participation in an exercise program. Clearly,more research is needed to
address the effect that physical activitymay have on improving the insulin resistant CHD
risk factor profile in the MS population.
Although the symptoms of MS may require modification in the mode, frequency,
and duration of physical activity, it is clear that persons with MSare capable of
participating in and achieving health-related benefits associated with physical activity.
Adherence to the exercise intervention imposed in training studies is high in subjects with
MS (86), which reflects their desire to improve physical fitness and functioning when
appropriate information and guidance is provided regarding how to exercise safely given
the limitations associated with MS. Gains in aerobic fitness following exercise training
can significantly improve mobility and the ability to perform activities of dailyliving,
which in turn, reduces the extent of 'normal' fatigue experienced inpersons with MS
(86). By improving mobility (86) and the quality of life, and by lessening fatigue (86)in
persons with MS (89,114), physical activity may, perhaps, reduce the high incidence of133
depression and suicide among persons with MS (86,103,105). In fact,women with MS
regard physical activity as an essential component for "coping with the physical demands
of the illness (113)."
Thus, it is essential that physical activity recommendationsare developed
specifically for persons with MS to overcome potential barriers prohibiting participation
in physical activity, and to reduce the development of physical inactivity-relatedmedical
problems. In this regard, the United States Surgeon General emphasizes the need for
research addressing preventative measures for reducing CHL) risk, specifically inwomen
and person with disabilities (123). The lack of sufficient data regarding appropriate
exercise prescription guidelines and exerciseresponses in persons with MS across the
range of disabilities is a major obstacle to convincing health care professionals to
incorporate exercise prescription into their existing treatment of patients with MS.
Current national physical activity guidelines, which recommend frequent,
nonvigorous forms of physical activity accumulating 30 minutes of activity eachday,
may be attainable by persons with mild to moderate MS. Although Petajan et al. (86) and
Shapiro et al. (108) examined the effect of exerciseon circulating levels of TG and HDL-
C, neither study evaluated changes in plasma insulin inresponse to exercise training,
which may be particularly importantinpersons who chronically use corticosteroids.
Thus, future research should focus on the effect that physical activitymay have on insulin
resistance and its associated CHD risk factors.